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CHAPTER 1
Introduction
He who cannot draw on three thousand years is living from hand to mouth.
Johann Wolfgang von Goethe, 1749-1832.
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2
1.1 A Stroll along the History of Medical Imaging
The history of modern western medicine1 goes back in time for more than two millennia,
revealing the story of an eternal struggle against diseases. Across the centuries, we have
come to realize how essential the observation of the human anatomy is: medical imaging as
we know it today is the result of such a process.
Before the Ancient Greek period, medicine and religion were strongly intertwined: dis-
eases were considered as punishments from the Gods and only curable with religious reme-
dies. It was only with Thales (ca. 624-546 BC) that humans turned their attention away from
the Gods and hypothesized the existence of four elements governing the entire Universe: air,
water, earth and fire. In the mid-fifth century BC, Alcmaeon of Crotone suggested that dis-
eases were simply a consequence of disequilibrium between such elements, and that among
the organs the brain was the most important. His ideas were later turned into a fundamental
philosophy by Hippocrates (ca. 460-370 BC), who is commonly recognized as the father
of rational medicine. Unfortunately, following the principles of the four elements, philoso-
phers disregarded the observation of the human body as a useless practice: diseases could
only be cured by expelling the elements in excess. Nevertheless, the investigation of the hu-
man anatomy survived and developed thanks to painters and sculptors, constantly aiming at
a perfect representation of the human body.
While the Ancient Greek period was turning to an end, it witnessed the life of its great-
est philosopher and biologist, Aristotle (384-322 BC). Among his many contributions, he
elaborated a physiological system to describe the functionality of the human body. His teach-
ings were passed on to his students, among who was Alexander the Great (356-323 BC),
whose conquests in the Mediterranean area facilitated the spreading of Aristotle’s philosophy
through the Hellenistic and Roman era. Alexandria, in Egypt, soon became the center of
the epoch’s knowledge: medical philosophers trained in Alexandria rediscovered the art of
dissection, thanks to the pluri-millenary tradition of mummification. It was within the school
of Alexandria that Democrito (ca. 460 BC) developed his atomistic theory, contrasting the
widespread philosophy of the four elements. A few centuries later, Alexandria hosted a Greek
physician whose theories were bound to rule the medical domain for more than a millennium:
Galen of Pergamum (ca. 129-200 AD). After completing his education in Alexandria, Galen
moved to Rome where he worked as doctor of gladiators: he performed the first brain and
eye surgical operations, acquired a profound knowledge of wound treatment, and promoted
first-hand observations of the human anatomy based on dissections and vivisections. Un-
fortunately, he also contributed to the theory of humours, connected with the elements of
Hippocrates, leading to severe limitations in disease therapy. Despite the valuable efforts of
many in anatomical studies, knowledge was still passed on through practical experience, and
there is no evidence of anatomical drawings in this period.
In the following centuries (ca. 476 AD), the Roman Empire fell, and its knowledge was
slowly transferred to the Byzantine Empire: influenced by the Koran, physicians once again
took distance from the exploration of the inner human anatomy: any cut inflicted on a human
being could lead to his soul departure. The study of the human body would have to undertake
1The historical information reported in this section were collected from the lectures on The History of Medicine
by Prof. Riva (Faculty of Medicine, University of Cagliari), available online at http://pacs.unica.it/biblio/history.htm.
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Figure 1.1: From left to right: Anatomical Sketches by Berengario da Carpi (1535), Leonardo
Da Vinci (1680), and Fabricius ab Acquapendente (1533-1619).
a long trip back to its source: passing first through the Moorish civilization in Spain, and then
finally returning to France and Southern Italy around the year 1000 AD.
The first Universities were founded around 1200 AD, the one in Bologna (Italy) being
the oldest in Europe. The first hospitals were built in the same period, and with them the
practice of dissection returned. Although medicine was considered an academic field, the
link between Universities and Hospitals was not formalized. The first University Clinic was
founded only four centuries later (around 1600 AD), in Leiden (The Netherlands). By this
time, the importance of reproducing images of the human body was well established: it all
happened during the Renaissance. The prototype of the Renaissance man embraced knowl-
edge from the most diverse fields, such as arts, anatomy, engineering, etc., with Leonardo
Da Vinci (1452-1519) being one of the most representative figures of this period. The finest
arts had to reproduce nature in its very details, and required a profound knowledge of the
human anatomy: Berengario from Carpi (1460-1530, Carpi-Italy) published the first anatom-
ical book with illustrations [1], emphasizing the beauty behind the discovery of the human
body; Fabricius ab Acquapendente (1533-1619) introduced colored illustrations (see Fig.
1.1), and Vesalius (1514-1564) published De Humani Corporis Fabrica in 1543, a collection
of anatomical views in woodcuts [2].
By the beginning of the XVII century, the valuable contribution of anatomical drawings
was largely recognized. The description of the human anatomy via illustrations became es-
sential in medical teaching. The idea of a scientific approach to research developed across the
Figure 1.2: From left to right: The first X-ray image, taken by Roentgen in 1896; The first
CT scanner prototype designed by Houndsfield; Sagittal MR image of the brain.
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(a) (b)
Figure 1.3: (a) Lobes in the brain. (b) Neural cells: the different nuclei form the gray matter,
while the axons bundle together in what is known as the white matter.
XVI-XVII centuries, thanks to Galileo Galilei: reproducibility of experiments and first-hand
experiences through senses constituted the basis of such a revolution. The microscope was
invented, laying the foundations for the cellular pathology theory which would lead, two cen-
turies later, to the use of colorants for lesion detection. Galileo’s background as a physicist
and the invention of the microscope originated a new wave of thinking: the human body was
considered as a machine, made of several parts (the organs) which needed to be analyzed
separately.
Medical imaging as we know it today moved its first steps in the XIX century: the use
of X-rays for imaging the human body was discovered in 1895 by Wilhelm Konrad Roent-
gen, marking the beginning of radiology [3] (see Fig. 1.2). Afterwards, new techniques were
developed: ultra-sounds for echography (1940, Dr. George Ludwig [4]), computerized to-
mography (CT, by Godfrey Hounsfield, 1967 [5]), nuclear medical imaging (first introduced
in 1950), and magnetic resonance imaging (MRI, first demonstrated in 1973 by Paul Lauter-
bur [6]). Nowadays, thanks to increased computational power and advanced technologies,
efforts are made to merge existent imaging modalities.
Our stroll started when the human body was nothing but a unique entity at the mercy of
Gods; walking through the centuries, we have come to value and increase our knowledge in
the anatomy and functionalities of different organs and cells; nowadays, we feel the need to
glue pieces together in a better understanding of how they interact within the whole system.
(a) (b)
Figure 1.4: The ventricles (a) are cavities filled with cerebrospinal fluid; located in the middle
of the brain (b), they serve as a cushion protecting the brain from concussions.
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Medical imaging has developed along this path, and will doubtlessly continue consolidating
its role.
1.2 Brain Anatomy in Magnetic Resonance Images
Located in the head and protected by the skull, the brain is probably the most complex organ
in the human body: a quote often attributed to E.M. Pugh states that if the brain were so simple
that we could understand it, we would be too simple to understand it. Whether this paradox
corresponds to truth or not is let to science to debate. Certainly, a thorough description of
the brain and its functions goes behind the scope of this manuscript: this section provides a
general overview of the brain anatomy, and introduces the structures involved in this research.
Functional areas and biological background
The brain can be divided in different functional areas (see Fig. 1.3.a): the frontal lobe plays
an important role in many cognitive functions like judgment, impulsive control, language, and
planning; the temporal lobe is predominantly involved in the auditory processing, speech and
vision semantic, and memory formation; the occipital lobe, receiving information from the
retina, is actively involved in visual processing, color discrimination, and motion perception;
parietal lobes integrate the sensory information perceived from different parts of the human
body. The different lobes form what is usually referred to as cerebral cortex. Finally, the
cerebellum plays an important role in the integration of sensory perception and motor output
and is connected to the motor cortex. From the biological point of view, the brain is composed
of cells: a distinction can be made between the gray matter, consisting of neuron’s bodies,
and white matter, consisting of axons connecting neurons (see Fig. 1.3.b). The complexity
of the brain can be appreciated considering that it is made of more than 100 billion neurons,
each connected to approximately 10.000 other neurons.
The Brain Ventricles - The brain ventricles are a system of cavities located in the center of the
brain and filled with cerebrospinal fluid (CSF) (see Fig. 1.4). The CSF serves as a cushion
for the brain, protecting it from concussions. The brain ventricles are surrounded by white
and gray matter structures, usually defined as periventricular structures.
Corpus Callosum - The corpus callosum is the largest bundle of white matter in the brain;
located above the brain ventricles, it allows communication between the left and right hemi-
spheres (Fig. 1.5.a).
Caudate Nuclei - The caudate nuclei (one for each hemisphere) are located within the basal
ganglia (a set of nuclei in the brain connected with several cortical and subcortical structures)
and play an important role in learning. Their position relative to the brain ventricles is shown
in Fig. 1.5.b.
Thalamus - The thalamus is located, symmetrically, in the proximity of the third ventricle
(see Fig. 1.5.c): among many other functions, it is responsible to encode and transmit pre-
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thalamic inputs to different areas in the cortex.
Hippocampus - The hippocampus is part of the limbic system, and is located in the medial
temporal lobe (see Fig. 1.5.d): it has an important role in memory and spatial navigation.
Amygdala - Also part of the limbic system (see Fig. 1.5.b), these almond-shaped groups of
neurons are involved in processing and memory of emotional reactions.
1.2.1 MR acquisition
Neuroscientists can rely on several imaging techniques to investigate brain’s anatomical and
functional properties, both in clinical practice and in research. Imaging modalities differ for
the type of information they provide: Multi Slice Computed Tomography (MSCT) and Mag-
netic Resonance Imaging (MRI) mainly focus on structural properties, while nuclear based
techniques such as Positron Emission Tomography (PET) and Single Photon Emission Com-
puted Tomography (SPECT) are more suitable for imaging the brain’s functional properties.
The research described in this manuscript is based on clinical MR images, whose main char-
acteristics are discussed in this section.
Magnetic Resonance Imaging was developed in the 1970s. Hydrogen nuclei present in
water and lipid are properly excited by radio frequencies waves in a strong static magnetic
field: the different relaxation properties of the nuclei can be weighted to generate images with
different intensity contrast. Important properties are the longitudinal relaxation time T1 and
the transverse relaxation time T2 (or the T2∗ variation); finally, proton-densities (PD) images
are acquired without considering the relaxation time. The MR technique presents several
advantages:
- images can be acquired at any plane in 3D;
- T1, T2, T2∗ properties can be weighted to provide different intensity contrasts;
- the patient is not exposed to radiation;
- contrast agents (like gadolinium) used for image enhancement have proved safer than
those used for X-rays and CT;
- aside for possible contrast administration, it is an entirely noninvasive technique.
The main drawback of MR is related to the applied magnetic field: patients with ferromag-
netic implants are generally not allowed in MR scanners.
In clinical settings, images can be acquired with an approximate isotropic resolution of
1mm3, applying a magnetic field of 1.5 Tesla: higher magnetic field (i.e. 3 Tesla) have
also become part of clinical routine, improving the spatial resolution. Depending on the
chosen protocol, brain tissues, such as gray and white matter, and CSF appear with different
contrasts, as shown in Fig. 1.6.
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(a) (b) (c) (d)
Figure 1.5: (a) Corpus Callosum (in white); (b) The caudate nuclei (in green) and the amyg-
dala (almond-shaped red blob); (c) The Thalamus (in blue); (d) The hippocampus (in violet).
1.3 The Alzheimer’s Disease
It was in 1901, when doctor Aloysius Alzheimer was presented with a case of a 51 year old
woman with cognitive and language deficits, and a loss of short-term memory. Alzheimer fol-
lowed the case, and when the woman died five years later, he was given her brain for further
examinations [7]. By means of staining techniques, Alzheimer and his team could highlight
the presence of amyloid plaques and neurofibrillary tangles in the brain. In a book published
in 1910, Emil Kraepelin used for the first time the term Alzheimer’s Disease to refer to the
pathology [7]. Since then, the scientific community has spent considerable efforts study-
ing the Alzheimer’s Disease (AD), trying to unveil the mechanisms behind its development,
introducing diagnostic tests, trying to detect biomarkers, and developing therapies.
The reasons behind such conspicuous efforts are to be found in the syndrome caused by
the disease: dementia. Defined as a progressive process of cognitive decline, dementia can be
caused by diseases or damages affecting the brain. The risk of developing dementia strongly
correlates with age. Fratiglioni et al. [8] showed that the percentage of people affected by
dementia almost doubles every five years beyond the age of 65: from 1% in the age range
60-64, up to 45% above 95. More recently, Wimo et al. [9] estimated that the societal costs
of health care for dementia in 2005 reached 315.4 billion dollars worldwide, of which more
than 72% was spent in developed continents (26.5% in North America, 28.1% in Asia, and
38.2% in Europe). Alzheimer Disease is the most common cause of dementia, accounting for
about 74% of the cases in North America (where AD was the 7th leading cause of death in
Figure 1.6: MR T1-weighted (left) and T2-weighted (right) axial views of the brain. In T1w
images, gray matter is in gray, white matter in white, and CSF in black. In T2w images, the
colors are inverted.
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(a) (b)
Figure 1.7: (a) Amyloid plaques and neurofibrillary tangles in AD; (b) MR T2w images of
brain ventricles in a healthy subject (left) and in AD (right): the ventricles are visibly enlarged
in AD, due to atrophy.
2004), 61% in Europe, and 46% in Asia2. Considering the high rate of conversion to AD, the
economical and social effects are bound to increase considerably in the future, if no remedy
is found. Emotionally, AD affects the life of the patient and his family drastically. The initial
loss of short-term memory is followed by a progressive cognitive decline: in its final and most
severe stage, the patient is unable to perform any simple task and needs constant supervision.
On average, the disease leads to death in about 7-10 years, and up to 20 years after the onset
of the symptoms.
Nowadays, no definitive cure exists for AD: available therapies can only slow down the
cognitive decline, and have been proved more effective when given in the early stage of the
disease [10]. Therefore, it is vital to improve our understanding of how the disease develops,
and to identify biomarkers sensitive to brain changes related to AD progression. The most
accredited hypotheses seek the causes of the disease in the pathology of amyloid and tau pro-
teins, which accumulate to form amyloid plaques and neurofibrillary tangles (see Fig. 1.7.a).
Consequently, neurons’ apoptosis and neuronal synapses loss spread in different regions of
the brain, causing drastic anatomical changes (i.e. atrophy) which can be highlighted with
imaging techniques. Many studies have shown a correlation between the progression of the
disease and the decrease of volume in periventricular structures, such as the hippocampus and
the amygdala [11–18]: a direct consequence is the enlargement of the brain ventricles [19],
clearly visible in MR images (see Fig. 1.7.b).
Alzheimer’s disease is at the end of a spectrum ranging from normal cognition to full de-
mentia. An important intermediate phase is the one referred to as Mild Cognitive Impairment
(MCI): patients with MCI present mild forms of memory loss, but are otherwise cognitively
capable. It has been shown that MCI subjects can eventually degenerate into AD [20]: nev-
ertheless, since not all MCIs turn into ADs [21, 22], defining MCI as an intermediate step
towards dementia would be far too reductive. Because of its connections with AD, and be-
cause of its cognitive implications, MCI has also been thoroughly investigated.
A definitive diagnosis of AD is possible only post-mortem, via microscopic examina-
tion. Expert clinicians can diagnose AD with an accuracy of 85-90%, but the final decision
2Information available from the European Commission Report on AD,
http://ec.europa.eu/health/ph information/dissemination/diseases/alzheimer en.htm
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is based more on symptoms and on the absence of alternative explanations, rather than on
specific biomarkers. Nuclear imaging techniques such as PET and SPECT might be useful
to diagnose dementia [23], but are not yet sufficiently specific in differentiating the causes
behind the syndrome. Techniques based on structural MR images have been developed to
estimate volumetric brain changes in AD: Boundary Shift Integral (BSI, [11]), Structural Im-
age Evaluation using Normalization of Atrophy (SIENA, [24]), and Jacobian Integration [25].
Comparisons between these methods have consolidated the strong correlation between brain
volume loss and AD progression [25, 26]. Local analyses, such as Voxel Based Morphome-
try and Deformation Based Morphometry, have also been used to highlight patterns of gray
matter loss through the spectrum from MCI to AD [27]. Several tests have been developed
to assess the cognitive functions of an individual. One of the most widely used is the Mini
Mental State Examination (MMSE), introduced by Folstein in 1975 [28]: the test consists of
several questions and tasks, and a maximum final score of 30 points indicates full cognitive
capabilities.
Although imaging techniques and cognitive tests have contributed considerably to the
study of AD, the quest for a final diagnostic tool is still ongoing. The goal of this research
was to improve our knowledge on how MCI and AD affect periventricular structures in the
brain, and how such effects correlate with cognitive decline. Measuring atrophy in periven-
tricular structures is a challenging task: the delineation of such small regions in clinical MR
images is time consuming and prone to errors. Moreover, it is not easy to predict beforehand
which structures will provide the best biomarkers for the disease. We have tackled these
issues by focusing on shape variations of the brain ventricles across different populations:
brain ventricles are more easily detectable in clinical MR images, due to the high contrast
of the CSF with the rest of the parenchyma; moreover, loss of volume in any periventricular
structure will directly be reflected in localized shape changes along the ventricular surface.
1.4 Shape Modeling and Analysis
Variations in biological shapes can reasonably be described by statistical models over a large
population of similar instances. The first attempt to formalize such approach was done by
Cootes et al. [29]: developed initially for two-dimensional (2D) images, the shape modeling
requires, as a first step, the establishing of corresponding locations through a large dataset.
The correspondence, particularly in medical images, should be based on similar anatomical
locations and/or similar position and shape characteristics: the final set of locations through
the entire dataset is referred to as Point Distribution Model (PDM). Manual identification of
corresponding landmarks might be possible in 2D, but its complexity increases drastically
when 3D shapes are considered: the task is time-consuming, prone to error, and poorly re-
producible. Thus, (semi-) automatic methods to generate PDMs are highly desirable. Several
methods have been proposed in the literature.
Spherical Harmonics (SPHARM) - First introduced by Gerig et al. [30], SPHARMs model
object shapes with spherical harmonics: the method is multi-scale and was successfully ap-
plied to the modeling of lateral ventricles. Nevertheless, the objects to be modeled require a
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spherical topology. Moreover, the parameters used to model the objects are not intuitively re-
lated to the object’s shape: thus, interpreting how changes in the parameters relate to changes
in shape is not straightforward.
Medial Representation (M-reps) - M-reps were first introduced by Pizer et al. [31]. Com-
plex objects are modeled at multi-scale as compositions of different figures: for each fig-
ure, a medial model is created and surface locations are parameterized relative to it. The
method was successfully applied to the analysis of kidney and hippocampus (see Styner et
al. [32]). Nevertheless, M-reps present some limitations: the definition of medial models
can be either manual (time consuming and error prone), or automated [33]: in this case, an
initial SPHARM-based parametrization is needed, which leads back to the requirement of a
spherical topology. Moreover, to detect medial models in elongated and thin structures (like
temporal horns) is a challenging task.
Minimum Description Length (MDL) - Rooted in an information theory framework, MDL
(Davies et al. [34]) is based on descriptive functions which are optimized with genetic al-
gorithms: first, a set of functions is used to identify corresponding locations; subsequently,
a PDM is built and its performances are tested relative to several error functions; finally, the
parameters defining the descriptive functions are tuned in order to maximize an objective
function. Although the MDL has been successfully applied to several anatomical structures
[35, 36], it still presents some limitations: the objective function is usually highly non-linear
and the genetic algorithms used for optimization increase the computational load consider-
ably, without guaranteeing an optimal solution.
Deformation Fields - Rueckert et al. [13] suggested a different approach to the analysis of
shape variations. The statistical model is built on the deformation fields obtained by non-rigid
registration: thus, the method does not require any pre-segmentation to isolate the objects of
interest. Moreover, being based on the entire dataset, it provides information on inter-objects
variability (e.g., in a brain dataset, changes of the brain ventricles are related to changes in the
surrounding structures). Still, the authors consider shape-based approaches to be preferable
when inter-object variability is not important, or when it might confound the analysis.
The ventricular system presents a very challenging shape: it is highly concave and there-
fore not easily reducible to a spherical topology. Moreover, the temporal and occipital horns
of healthy subjects can be very thin, especially when imaged in clinical setups. Part of the
research described in this thesis aimed at developing a new technique for shape modeling
which could correctly represent shape variations in brain ventricles.
Regardless of the particular modeling technique, once the PDM has been acquired and
validated, different shape analyses can be performed. Intra-population variability can be
studied with Principal Component Analysis (PCA) [29]: eigen-analysis in the shape-space
results in an average shape model and orthogonal directions (eigen-vectors) along which one
can move to analyze modes of variations. Inter-populations variability can also be investi-
gated: thanks to the correspondence property of PDMs, shapes in one population can locally
be compared with shapes in another population via non-parametric statistical tools, such as
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permutation tests [37]. The results presented in this thesis are based on both these kinds of
analysis.
1.5 Structure of this thesis
This manuscript is organized as a collection of scientific papers: consequently, a certain
degree of overlapping is to be expected through the most general parts of the following sec-
tions. The context and novelty of each chapter are described here: Chapter 2 presents a new
technique to model the shape of challenging structures with comparable meshes. The new
algorithm is thoroughly validated on challenging synthetic shapes, and applied to the mod-
eling of two populations of brain ventricles: healthy subjects and ADs. Comparisons with
other approaches show the good performances of our method. In Chapter 3, the new shape
modeling algorithm is applied to two populations of AD and age-matched healthy individu-
als, showing that only well-defined areas of the ventricular surface differ significantly, and
highlighting the corresponding periventricular structures. In Chapter 4, permutation tests and
support vector machines are used to prove the existence of ventricular shape-based biomark-
ers for AD in clinical MR images, and to assess their performances. Differences between
Memory Complainers, MCIs, and ADs are investigated in Chapter 5, focusing both on the
severity and extent of atrophy in periventricular structures. Finally, in Chapter 6 the whole
spectrum of cognitive impairment (as measured by the MMSE score) is correlated, via linear
regression, with local enlargements in the brain ventricles. Chapters 7 and 8 summarize and
conclude the manuscript.
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Colored Figures from Chapter 5
Figure 5.3 (page 86) Local differences in ventricular shape between cognitively healthy and
memory complainers, subjects with MCI and subjects with AD. Local shape differences be-
tween groups are represented by color-coded p-values (p values > 0.01 are color-coded in
blue).
Figure 5.4 (page 87) The direction of the displacement vectors in these images demonstrates
that changes between an average cognitively healthy subject and an average AD occur as a
result of ventricular enlargement.
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GAMEs: Growing and Adapting MEshes for Fully
Automatic Shape Modeling and Analysis
Reasonable people adapt themselves to the world. Unreasonable people attempt to adapt
the world to themselves. All progress, therefore, depends on unreasonable people.
George Bernard Shaw, 1856-1950.
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This chapter is reprinted from:
Medical Image Analysis 2007, Vol. 11(3)
Authors: L. Ferrarini, H. Olofsen, W.M. Palm, M.A. van Buchem, J.H.C. Reiber, and F.
Admiraal-Behloul
Title: GAMEs: Growing and Adapting MEshes for Fully Automatic Shape Modeling
and Analysis, pp. 302-314, Copyright (2007), with permission from Elsevier
Abstract This paper presents a new framework for shape modeling and analysis, rooted in
the pattern recognition theory and based on artificial neural networks. Growing and Adaptive
MEshes (GAMEs) are introduced: GAMEs combine the Self-Organizing Networks which
Grow When Required (SONGWR) algorithm and the Kohonen’s Self-Organizing Maps (SOMs)
in order to build a mesh representation of a given shape and adapt it to instances of similar
shapes. The modeling of a surface is seen as an unsupervised clustering problem, and tack-
led by using SONGWR (topology-learning phase). The point correspondence between point
distribution models is granted by adapting the original model to other instances: the adapta-
tion is seen as a classification task and performed accordingly to SOMs (topology-preserving
phase). We thoroughly evaluated our method on challenging synthetic datasets, with different
levels of noise and shape variations, and applied it to the analysis of a challenging medical
dataset. Our method proved to be reproducible, robust to noise, and capable of capturing real
variations within and between groups of shapes.
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2.1 Introduction
Statistical shape modeling and analysis have been increasingly used during the last decade
as a basis for image segmentation and interpretation. Successful 2D-applications have been
described in the literature [1]. Building a statistical model often requires the establishing
of correspondence between shape surfaces over a set of training examples. Defining corre-
sponding points on different shapes is not trivial: in some 2D applications, manual landmark
definition might be possible but it becomes unpractical when 3D/4D shapes are considered.
Different techniques have been proposed in literature to address this problem. In [2], the
authors successfully applied a shape representation based on spherical harmonics (SPHARM)
to the analysis of brain ventricles. The SPHARM is a multi-scale approach, which allows for
smooth shape representation, even at a very fine scale. The two major limitations of this
method are (1) the need of pre-processing steps to generate a spherical-topology object, and
(2) the non-intuitive nature of the parameters, which does not allow for an easy interpretation
when significant shape differences are found. In [3], the authors introduced deformable me-
dial representations (M-reps) for segmentation of 3D medical structures: they successfully
applied their method to the analysis of kidney and hippocampus (see also [4]). The M-reps
are multi-scale and can represent objects as composition of multiple figures related with each
other. A key step to build up M-reps is the construction of medial models, which can either be
created manually (time consuming and error prone), or generated automatically as suggested
in [5]. Nevertheless, the first step described in [5] requires a boundary parametrization using
SPHARM: thus, the spherical-topology constraint still remains. Moreover, to identify medial
models in thin elongated structures is not a trivial task. Another solution, rooted in an infor-
mation theory framework, is the Minimum Description Length (MDL) approach described
in [6]: the authors suggest to (1) use a descriptive function to describe corresponding points
on different shapes, (2) build up a first model, and (3) evaluate its performances through an
objective function. New models are generated with new parameters which are tuned in order
to optimize the objective function. The process continues until convergence. The MDL has
been successfully applied to the modeling of different structures [7, 8]. Nevertheless, due
to the highly non-linear objective function, genetic algorithms are used for the optimization:
the computation load is therefore high, and a general global optimum is not granted. A com-
pletely different approach is the one suggested in [9]: instead of modeling shapes, the authors
suggest to model deformation fields obtained by non-rigid registration. This approach has
several advantages when the whole anatomy of a certain organ is studied: it does not require
prior segmentation and it provides inter-object relationships. On the other hand, the authors
consider shape-based approaches to be a better choice whenever the inter-object relationship
is not important or confounds the modeling process. All the modeling approaches described
before can be divided into two groups: groupwise and pairwise. Groupwise analyses aim at
optimizing an objective function over the whole dataset while creating the statistical model
[6], while pairwise solutions start with a representative shape of the dataset and build up a
model rooted in it. Many advantages of groupwise analysis have already been highlighted in
the literature [7]; nevertheless, in a recent study on non-rigid registration and segmentation
[10], the authors compared pairwise and groupwise approaches, showing that the simpler
framework of pairwise methods performed systematically better.
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Figure 2.1: Growing Phase. During the unsupervised clustering algorithm, a model Mj
grows and adapts to learn the topology of the input space Pj . In the adapting phase, the input
is the Mj model (output of the growing phase), and only the SOM part of the algorithm is
used (box with dashed line).
The method presented in this work is a pairwise approach to shape modeling. The shape-
modeling problem can be summarized as follows: given a set of shapes, one needs to generate
Point Distribution Models (PDMs) which describe them. Since shapes need to be compared,
a correspondence between points in the PDMs has to be established. Three questions rise:
How many nodes are needed? Where should they be located on the surface? How can one
define correspondence across shapes? In this work, we introduce a pattern recognition frame-
work to address these questions. In a first phase, a topology-learning unsupervised clustering
algorithm is used to select the optimal number of nodes (clusters) and their locations in the
input space (3-dimensional space of surface points). In a second phase, the correspondence
problem among models is tackled as a classification task: the generalization property of a
classifier is used to match unseen cases to similar previously seen points, preserving the
topology learned through unsupervised clustering. Growing and Adaptive MEshes (GAMEs)
are introduced to implement both the unsupervised clustering and the adapting algorithms.
The growing phase of GAMEs (unsupervised topology-learning clustering) is based on Self-
Organizing Networks which Grow When Required (SONGWR), introduced in [11] (see also
[12] and [13] for more details on growing cell structures): SONGWR proved to be (1) more
data-driven while growing, and (2) faster in learning input representation, when compared
with previous models. The adaptation phase of GAMEs is based on Self-Organizing Maps
(SOM), which have been proved to be perfectly topology-preserving [14]. To the best of
our knowledge, this is the first work showing how a combination of growing structures and
self-organizing maps can be used to address the issues of shape modeling and analysis.
In this paper, we provide a thorough evaluation of our method. Working with challenging
synthetic shapes, we tested GAMEs’ robustness, reproducibility, and accuracy in detecting
landmarks. We used the outcome of GAMEs to build statistical models and tested their ability
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Figure 2.2: Top Growing phase: The neural network (model) grows and adapts to the set of
surface points representing the shape, detecting the optimal number of clusters (nodes) and
their locations. Bottom Adapting phase: a model is adapted to a new shape.
of representing real variations within and between groups of shapes. We also successfully
applied GAMEs to the analysis of shape variation in populations of brain ventricles, both for
healthy elderly individuals and for patients subject to Alzheimer’s disease.
The rest of the paper is organized as follows. In section 2.2 we provide an overview of
our method. In section 2.3 the methods used to evaluate and compare different PDMs are
presented, together with the results for synthetic shapes. Section 2.4 shows the successful
modeling of the brain ventricles in Magnetic Resonance Imaging (MRI). We finally give a
detailed discussion of the proposed method, highlighting our main contributions, and provide
a general conclusion.
2.2 Method
The shape modeling technique presented in this work is based on self-organizing networks
which grow when required (SONGWR), introduced in [11]. The general aim of these net-
works is to provide (learn) an accurate topological representation of a given input space.
Figure 2.3: Synthetic shapes used for validation: (a) XShape, (b) S-shaped Tube, and (c)
Sphere. Some characteristics of these shapes can vary according to the test one wants to
perform. XShape: distance between tubes (X dist) and radius of the tubes (X rad); S-shaped
Tube: length of the straight sections (S dist) and radius of the tube (S rad); Sphere: length of
the protrusion (P dist). Table 2.1 shows the corresponding parameters.
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Marsland used his networks for two main applications: novelty detection in a general feature
space, and mapping of unknown environments for robots’ explorations [11, 15]. Regardless
the application, the core of the algorithm is the same (see Fig 2.1): the network (in our case
a mesh) is initialized with only few nodes, not connected with each other, and randomly dis-
placed in the input space. Every time a new data point is drawn from the input space, the best
matching node is selected among those forming the network at the current state; if the accu-
racy with which the node represents the data is below a certain threshold aT , a new node is
added, and new connections are created among neighbor nodes (topology-learning behavior);
otherwise, the position of the best matching node is adapted. Data points are drawn from the
input space until convergence is reached (that is the topology of the network does not change
significantly anymore). In Appendix 2.7, a detailed description of the SONGWR algorithm
is provided.
The GAMEs method is, to a large extent, similar to the SONGWR method. The main
difference is that we adapt the mesh using the Kohonen SOM algorithm: when the mesh is
adapting, the motion of the best matching node affects the neighboring nodes as well (see
Appendix 2.8 for a recall of the SOM algorithm). The use of the SOM algorithm allows
smooth network changes and topology preservation [14]. In the frame of shape modeling
and analysis, the input space is three-dimensional and the training data sets are the surface
points of the object to be modeled. The GAMEs approach goes through two main steps: (i)
the creation of the first model, based on a representative instance of the shapes, using the
growing and adapting phase, and (ii) the adaptation of the model to all other shape instances
of the data set.
2.2.1 Growing phase: learning the topology
Let us consider a dataset of segmented objects T = {O1, ..., On}. For each instance in T , the
cloud of surface points is detected: {P1, ..., Pn}. As a first step, one needs to create a network
(or model) of a given cloud Pi (either chosen as a good representative of the training set, or
generated as an average based on the training set). Our input space is the set of surface points
Pi: iteratively, all the surface points are randomly extracted and given to the network. The
whole process can be seen as an unsupervised clustering of the surface points: the new nodes
added to the network are new clusters, and the new edges encode neighborhood information.
The network grows and adapts until convergence is reached: that is, the network structure
does not change significantly when new inputs are given.
One of the key parameters of a general clustering technique is the similarity measure
(or distance) used to select the best matching node (cluster). The SONGWR method uses
the Euclidian distance. In the GAMEs method, once the network has converged, we further
finalize it by repeating the whole process using the Mahalanobis distance when looking for
the best matching node. Studying the effect of different distance measures is not in the scope
of this paper. In section 2.4 we show how the use of Mahalanobis distance improves the
overall performances of the PDM in a medical application. Figure 2.2 illustrates the growing
and adapting phase of the GAMEs.
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2.2.2 Adaptation phase with topology preservation
After the convergence of the Mahalanobis loop, the final modelMi = {Ai, Ci} represents the
given cloud of points: Ai and Ci being the set of nodes and edges respectively. The original
training set includes several instances of similar shapes T = {O1, ..., On}: in order to per-
form shape analysis, one needs comparable models of each instance {M1, ...,Mi, ...,Mn}.
We define two models (Mi,Mj) comparable if each node in model Mi is uniquely associated
with a node in Mj , and vice versa: the two models can be compared on a node (local) basis.
Results of the shape analysis are meaningful only if corresponding nodes are representative
of topologically equivalent regions (this is tested by assessing the performances of the final
PDM, as illustrated in sections 2.3.3, 2.3.4, and 2.3.5).
Given the initial model Mi and a new cloud of points Pj , a new comparable model Mj is
generated through the adapting phase: this process can be considered as a classification task,
in which the model Mi is the classifier, and the surface points in Pj the objects to classify. As
illustrated in Fig. 2.1, the only difference between this phase and the first one is that nodes and
edges are not added nor removed. For each point, we identify the best matching cluster and
adapt it and its neighbors as in SOM. The whole set of surface points is given iteratively until
convergence is reached: the final model Mj is comparable with Mi. Moreover, by adapting
the clusters as in SOM, the topology is preserved. The set of models {M1, ...,Mi, ...,Mn}
is a PDM: for each node (point) in Mi, the set of corresponding nodes in the other models
define its distribution in space.
2.3 Evaluation methods for PDMs: Validation on Synthetic
Data
Good performances in shape modeling and analysis rely on a good PDM, whose perfor-
mances can be assessed by different tests discussed in this section. The synthetic shapes used
for the evaluation of our method are shown in Fig. 2.3: XShape, STube, and Sphere. In Table
2.1 we report the geometrical characteristics of each shape, how they vary in the different
tests, and how many shapes were generated for each test.
These shapes were chosen because they resemble realistic situations in anatomical struc-
tures. Some of them present branches: the XShape was chosen to simulate bifurcations with
different thickness and angles. The variable protrusion in the sphere simulates structures
which can collapse, like temporal horns of brain ventricles. Moreover the highly symmetri-
cal shape of the sphere makes it a challenging shape to model: many false modes of variation
can be identified as a result of wrong adaptations along the surface. The STubes can present
different curvatures, resembling blood vessels (like the cerebral vasculature).
2.3.1 Reproducibility
In both the unsupervised clustering and adapting algorithms, the list of surface points is ran-
domized to assure a more homogenous growth and adaptation for the network. Reproducibil-
ity over different runs is an important requirement which needs to be evaluated.
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Table 2.1: Dimensions and variability in synthetic datasets (see also Fig 2.3). n is the number
of shapes generated for each dataset.
Shape Surf. Pts. Shape Dimensions n
average shape Characteristics (Voxels)
(Surf. Voxels) µ σ
XShape 3800 X dist 40 5 40
X rad 5 1.25
STube 6490 S dist 70 3.3 40
S rad 5 1.67
Sphere 1290 P dist 10 3 40
The reproducibility test consists in generating n models {M1i , ...,Mni } starting from the
same cloud of points Pi, and evaluating both the average accuracy with which the models
represent the cloud of points Pi, and the average dissimilarity between models. Given Pi =
(p1i , ..., p
N
i ), with N = ]{Pi}, and a corresponding model Mi = {Ai, Ci}, the accuracy with
which Mi approximates Pi is given by:
Acc(Mi, Pi) =
1
N
∑
k=1..N
||pki − ski ||, with ski = arg min
q∈Ai
||q − pki ||, (2.1)
where ski is the closest node to p
k
i (according to a pre-defined distance function). The
average accuracy is given by averaging all the Acc(Mi, Pi) through the n models of Pi
{M1i , ...,Mni }.
To define how similar (or dissimilar) two models are is not trivial. Two models can differ
both in terms of nodes (number and locations) and in terms of edges (number and lengths).
Given a model M
′
i , its energy is defined as the total squared length of its edges:
E
′
i =
∑
q=1..]{C′i}
||edgeq||2. (2.2)
Given two models M
′
i and M
′′
i , the dissimilarity between them is defined as:
d(M
′
i ,M
′′
i ) = Acc(M
′
i ,M
′′
i ) +Acc(M
′′
i ,M
′
i ) + (1−
Em
EM
), (2.3)
where Acc(M
′
i ,M
′′
i ) is the accuracy of model M
′
i in approximating the nodes of model M
′′
i
(in contrast to the points of Pi, see equation 2.1), and
Em = min(E
′
i , E
′′
i ), EM = max(E
′
i , E
′′
i ), (2.4)
as defined in [11]. The average dissimilarity is given by averaging all the possible d(M
′
i ,M
′′
i )
over {M1i , ...,Mni }.
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Table 2.2: Reproducibility test: results are given as mean (standard deviation), and averaged
over n = 20 cases.
Dissimilarity Accuracy N. Nodes N. Edges
(V oxel) (V oxel)
X Shape 2.8 (0.11) 1.62 (0.001) 163 (0) 460.85 (4.12)
S Shaped Tube 2.81 (0.08) 1.63 (0.001) 295 (0) 840.35 (5.21)
Sphere 2.83 (0.15) 1.62 (0.002) 64 (0) 177.25 (2.88)
Results are reported in Table 2.2. The average accuracy resulted in 1.62 voxels, and the
average dissimilarity between the models was 2.8 voxels. In these experiments the maximum
number of nodes in the network was upper-bounded by the number needed to guarantee the
required accuracy (standard deviation is zero). The results also show very small standard
deviations for the total number of edges (always below 2% of the mean value), which was
not constrained. These results proved the reproducibility of our method.
2.3.2 Robustness to noise
The robustness to noise test is similar to the reproducibility one: only in this case noise
is randomly added to the cloud of points before creating a new model. Starting from the
original cloud of points Pi, n new clouds are generated {P 1i , ..., Pni } by randomly moving
p% of the nodes in space, and removing q% of them. We generated 20 data sets for each
shape with different levels of noise. Results are reported in Table 2.3: both accuracy and
dissimilarity did not change significantly compared to the reproducibility test. The algorithm
proved to be robust to noise.
2.3.3 Accuracy in landmark detection
Correspondence between nodes in different models is useful only when corresponding nodes
represent similar landmarks (i.e. similar anatomical locations for medical datasets). When a
model is deformed into a new mesh, nodes representing important landmarks on the original
shape should move in locations close to equivalent landmarks on the new shape. Given a set of
shapes {O1, ..., On}, one manually identifies t landmarks on each of them {l11, ..., lt1, ..., l1n, ..., ltn},
where landmarks lj1, ...l
j
n (j = 1..t) represent similar locations through the set of shapes.
Starting from a shape Oi, a model Mi = {Ai, Ci} is built up, with Ai = {s1i , ..., sNi } being
the set of nodes. For each landmark lji on shape Oi, the best matching node (the closest ac-
cording to a pre-defined distance function) sji ∈ Ai is automatically identified. Comparable
models are then generated, adapting Mi to the other shapes: {M1, ...,Mn}. The nodes pre-
viously labeled in Mi (s
j
i ∈ Ai) can be followed in the new model Mr: sjr ∈ Ar, j = 1..t.
The average error for Mr is evaluated averaging the distances between the landmarks on Or
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Table 2.3: Robustness to Noise test (averaged over n = 20 cases). Results are reported (in
voxels, as mean(std)) for the three noise conditions (p% - q%), both for Dissimilarity (first
column) and Accuracy (second column).
60%-10% 70%-10% 70%-20%
X Shape 2.75 1.63 2.74 1.64 2.74 1.64
(0.1) (0.003) (0.1) (0.003) (0.11) (0.003)
S Shaped Tube 2.76 1.64 2.74 1.64 2.74 1.64
(0.09) (0.002) (0.08) (0.002) (0.07) (0.002)
Sphere 2.78 1.63 2.77 1.64 2.76 1.64
(0.17) (0.005) (0.15) (0.005) (0.17) (0.004)
({l1r , ..., ltr}) and sjr ∈ Ar, j = 1..t:
AvgDistr =
1
t
∑
j=1..t
||sjr − ljr||, sjr ∈ Ar, ljr ∈ Or. (2.5)
The final error is given by averaging through all the shapes and models1. For the STube and
Sphere cases, critical locations were identified and studied (see Fig. 2.4). Table 2.4 reports the
average error for each landmark and for the whole set. For the STube, the averaging global
error was 2.86 voxels (σ = 0.75 voxels); for the Sphere the global error resulted in 3.09
voxels (σ = 0.69 voxels). We can compare these results with the landmark errors reported
in [8]. In their work, the authors compared different methods for model building: SPHARM,
DetCov, and MDL. These methods were applied to both lateral ventricles (LatV) (analyzed
separately) and femoral head (FH). The SPHARM algorithm resulted in an average error
of 7.24 mm ([4.83-14.48] voxels) for FH, and (in average) 4.40 mm ([2.93-4.68] voxels) for
LatV; both DetCov and MDL were comparable with manual selection, resulting in an average
error of 4.15 mm ([2.77-4.41] voxels) for LatV, and 3.30 mm ([2.20-6.60] voxels) for FH.2
1While evaluating the error in equation 2.5, it is important to use the nodes sjr corresponding to the nodes s
j
i
automatically detected on the first model. If one used, for each shape Or , the best matching nodes in Mr , the final
error would be much smaller.
2Unfortunately, in [8] no information was given on the image resolutions. Nevertheless, concerning the lateral
ventricles, the authors refer to a dataset used for schizophrenia studies. In other works on schizophrenia from the
same authors [4, 16], the images acquired were high resolution T1, with a voxel size of 0.94x0.94x1.5 mm3. The
error range in voxel is given considered both the slice thickness and the in-plane resolution as extreme cases. The
Table 2.4: Accuracy in following critical points. Results are given (in voxels) as mean (std)
(averaged over n= 40 cases per shape).
Point 1 Point 2 Point 3 All Points
STube 2.93 (0.89) 2.91 (0.66) 2.74 (0.68) 2.86 (0.75)
Sphere 3.09 (0.69) - - -
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Figure 2.4: Given a shape, we identify important locations (a) and the corresponding best
matching nodes in the model (b).
2.3.4 Shape analysis validation
The performances of a statistical model are assessed by evaluating the following functions,
as described in [7]:
• Compactness (C): number of parameters needed to describe 90% of the total variation
in the dataset;
• Reconstruction Error (R): accuracy with which the model can represent shapes in the
training set;
• Generalization Error (G): accuracy with which the model can represent previously
unseen shapes;
• Specificity Error (Sp): average dissimilarity between shapes in the training set, and new
shapes generated by the model.
Given a set of models, a Principal Component Analysis (PCA) can be used to identify
the average model and its main modes of variation, needed to cover up to 90% of the total
variation in the training set. The modes are represented by the first k eigenvectors {e1, ...ek}
and eigenvalues {λ1, ..., λk}. Starting from the average model, new models can be generated
by adding a linear combination of eigenvectors, where the coefficients are constrained by a
function of the corresponding eigenvalues. Under these conditions, the functions previously
introduced can be formalized as:
• C(k) = ∑km=1 pm, with pm = λm∑
i=1..n λi
: the percentage of variance in the dataset
which is covered by the first k modes of variation. A better model requires a smaller
number of modes to cover the same amount of variance;
• R(k) = 1n
∑n
i=1 |Sni (k)− Si|: the average accuracy in approximating the n shapes of
the training set using k modes. Si is the original shape, while Sni (k) is its approxima-
tion through a model based on all the n shapes;
femoral images were acquired through computer tomography (CT): a standard voxel size for CT is 0.5x0.5x1.5
mm3.
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Table 2.5: Shape analysis test on synthetic data. For each shape we report the first two modes
of variation (% of variation covered, and cumulative %), and the total number of other modes
with the cumulative %. We also report the ranges for Reconstruction, Generalization, and
Specificity errors.
Shape Main Modes % R G Sp
First Second ] Others (voxels) (voxels) (voxels)
(cum.) (cum.) (cum.)
XShape 60% 31% 0 [0.4 - 1.2] [0.5 - 1.4] [2.7 - 3.5]
(60%) (91%) (91%)
STube 65% 23% 1 [0.4 - 1.0] [0.5 - 1.1] [3.0 - 3.8]
(65%) (88%) (90%)
Sphere 70% 3.5% 13 [0.2 - 0.3] [0.2 - 0.3] [1.2 - 1.5]
(70%) (73.5%) (90%)
• G(k) = 1n
∑n
i=1 |Sn−1i (k) − Si|: for a given i, the shape Si is approximated by a
model generated with all the other n−1 shapes, and considering the first k modes. The
approximation is indicated as Sn−1i (k);
• Sp(k) = 1ns
∑ns
i=1[Diss(Si(k), ObjCls)], with
Diss(Si(k), {ST1 , ..., STn }) = 1n
∑n
i=1 |STi (k) − Si|: is evaluated by creating ns =
100 instances Si(k) of the object class according to the model (using the first k modes),
and averaging the dissimilarity between them and the shapes in the training set STi .
Which function should be regarded as the most important one depends on the application.
When the statistical model is used to segment objects in new datasets, the specificity and
generalization errors are very important (the model should not generate illegal shapes, nor
being overtrained). When we analyze shape variations within a population or between groups,
the reconstruction error becomes the most important index: models have to be accurate in
order to draw correct conclusions. For each shape, we applied the PCA on 40 instances
(see Table 2.1): results are reported in Table 2.5. The right number of main modes was
detected in each class, and the identified modes reflected the variations artificially introduced
in the datasets. For the Sphere case, one important mode of variation was detected (covering
almost 70% of the total variation), and other 14 modes all below the 3.5%. The explanation
for all these extra ”small” modes is the highly symmetrical shape of the Sphere object: nodes
describing the sphere are more prone to registration errors during the alignment of the shapes,
and this accounts for many small modes of variations in which nodes slightly move on the
surface.
2.3.5 Local shape analysis
Another criteria to assess the performances of a PDM is the analysis of local shape differences
between populations. A good PDM should capture local shape characteristics when compar-
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ing different groups: in order to validate this property, one can generate two populations of
similar objects and introduce artificial changes in the average shape of one population. Sub-
sequently a PDM is generated to model all the objects in the two populations and the final
models are compared statistically. This is done through permutation tests, a statistical tool
which has already been successfully applied to the analysis of medical images (see [17] and
[18] for a description of the method and applications). The problem can be formulated as fol-
lowing: given two populations G1 and G2, are the shapes in G1 significantly different from
those in G2? If the answer is positive, is it possible to localize the differences on the average
surface? In terms of feature space, the first question can be reformulated as ”are G1 and G2
separable in the feature space?”, while the second question seeks for features which mostly
differentiate the two populations. Outcome of the permutation test is, in the first place, a p
value for the omnibus hypothesis ”the two groups G1 and G2 are drawn from the same pop-
ulation”. Moreover, we obtain a p value for each node in the model (corrected for multiple
tests), telling us whether the distribution of that node in space is the same in G1 and G2 or
not.
Two populations of STubes were created:
• Population 1: starting from the average shape, 20 instances were created with different
radius (normally distributed, with µ = 5 voxels, σ = 1 voxel);
• Population 2: same as population 1, but in two locations the average radius and stan-
dard deviations are different (location 1: µ = 10 voxels, σ = 2 voxels; location
2: µ = 2 voxels, σ = 0.4 voxels). See Fig. 2.5.a and Fig. 2.5.b.
The omnibus hypothesis was rejected with p < 0.01, indicating that the two populations
are globally significantly different. Local p values were also evaluated and mapped on the
average shape (see Fig. 2.5.c). The map shows the lowest p values exactly at the locations
where we artificially introduced different mean values for the radius. We would like to point
out that almost every location on the shape was found to be significantly different. The tubes
were generated through splines: changing radius in two locations slightly and systematically
affects the entire shape. Because the difference in the second group is systematic, permutation
tests correctly highlighted it as significant. Further analysis could include the amount of
displacement each node is subject to, while moving from the average shape of population 1
to the average shape of population 2: this would facilitate further investigations in the areas
highlighted by the permutation tests.
2.4 Application to brain ventricles
The brain ventricles are in the center of the brain, surrounded by gray and white matter struc-
tures which undergo atrophy when affected by Alzheimer Disease (AD) (see Fig. 2.6). Any
change of volume or shape occurring in these structures must affect the shape and volume of
the ventricles. Shape analysis can highlight local variations which can directly be associated
with adjacent areas, improving our knowledge on how AD affects the peri-ventricular brain
structures.
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Figure 2.5: Average shapes for population 1 (a) and population 2 (b). The second population
is similar to the first one except in two locations, where the radius (in average) changes.
(c) Statistical map for shape comparison: the local p values are color-coded on the surface,
indicating the areas of most significant difference between the two populations.
We applied our method to study shape variations of brain ventricles in healthy elderly
and AD subjects. Twenty-nine patients with probable AD (12 men, mean age 73 years, age
range 60-83 years) and 25 volunteers with normal cognitive function (11 men, mean age 74
years, age range 64-89 years) were included. MRI was performed on a 1.5 Tesla MR-system
(Philips Medical Systems, Best, The Netherlands) using the following pulse sequences: Dual
fast spin-echo (proton density and T2 weighted), time to echo (TE) 27/120 ms, repetition
time (TR) 3000 ms, 48 contiguous 3 mm slices without an interslice gap, matrix 256x256,
field of view (FOV) 220 mm. FLAIR (fluid attenuated inversion recovery): TE 100 ms, TR
8000, 48 contiguous 3mm slices without an interslice gap, matrix 256x256, FOV 220 mm.
For shape modeling purposes, all images were corrected for brain-size and orientation by
linear mapping into a stereotaxic space using an automatic affine 12-parameters registration
[19]. The LUMC T2-weighted brain template for geriatrics was used as target image [20]. A
template-based fuzzy classifier [21] was used to fully automatically extract the cerebrospinal
fluid (CSF): interactive 2D tools were then used to re-label the lateral and third ventricles as
ventricles.
The most suitable statistical model was chosen experimenting with different thresholds
aT (0.01, 0.025, and 0.05), and different initial shapes (a single case visually selected out
Figure 2.6: The brain ventricles are located in the center of the brain and surrounded by white
matter and gray matter structures generally affected by dementia. We refer to right and left
from the patient’s point of view.
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Figure 2.7: PCA performances for statistical modeling of the ventricular shapes in the control
group, given as functions of the number of modes. Increasing the accuracy from 0.025 to
0.05 does not improve the model significantly. Using an Average shape is generally better
than using a good representative from the Control.
of the Control population, and the average ventricle of the control population3). Results for
Compactness, Reconstruction Error, Generalization Error, and Specificity Error are shown
in Fig. 2.7 for the control population. Table 3.1 shows the number of nodes and an indication
of the adaptation time for different thresholds (average of controls used as initial shape). The
use of an average initial shape gives slightly better results than an individual initial shape,
when using the same threshold value aT . Moreover, increasing the accuracy improves the
final performances. The difference between average- and individual- initial shape was not
pronounced, indicating that, in this application, the algorithm is not significantly sensitive to
this initial choice. With respect to the accuracy threshold, aT = 0.025 and aT = 0.05 gave
significantly better results than aT = 0.01, while the difference between 0.025 and 0.05 was
not relevant. In order to keep a low computational load, we used aT =0.025, in combination
with an average initial shape, for the rest of the experiments. Results under these conditions
are shown in Table 2.7, for both controls and AD subjects.
In section 2.2 we stated that the Mahalanobis distance plays an important role while
building up the statistical model. In Fig. 2.8 we compare the performances obtained for the
Controls with (WM) and without (WoM) the use of Mahalanobis distance (aT = 0.025, and
3In order to obtain an average ventricle, one first needs to build a voxel-count map of all the controls: this map
is the sum of all the control binary images. A typical ventricle is then obtained by setting a threshold (to 20) on the
voxel-count map.
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Table 2.6: Computation load for different values of the aT threshold. The table shows the
total number of nodes needed to model the shape, and the average time needed to adapt the
model to a new instance (in min., mean ± std.).
Num. Nodes Adaptation Time (min.)
aT = 0.01 337 2 ± 1
aT = 0.025 844 6 ± 2
aT = 0.05 1689 16 ± 4
average control shape as a starting point): the WoM model results more compact, requiring
only 7 modes to cover up to 90% of the total variation in the dataset (the WM model requires
11 modes, which are enough for the WoM to reach 100% of covered variation). Nevertheless,
when the reconstruction error is considered, the WoM model performs worse than the WM
model. Only when all the 11 modes of the WoM model are used, the error is comparable
with the WM one: but statistical model usually only considers the first k modes of variation
needed to cover the 90% of total variation. Thus, the WoM error, using up to 7 modes of
variation, would present a higher error. For what concerns the generalization error, the WoM
model performs worse than the WM even when all the 11 modes are considered. Finally,
the specificity error does not differ between the two models. We have performed the same
analysis on the AD group and got similar results.
The performances of our method can be compared with those reported in [8], for both
SPHARM and MDL approaches. When applied to lateral ventricles (left and right ventricles
considered separately), the MDL resulted in 20 modes of variation, with a generalization error
between 3 and 1 mm, and a specificity error between 1.55 and 1.8 mm (SPHARM provided
slightly worse results). These results are slightly better than those obtained with our method,
but in our case the whole ventricular system (with the exception of the 4th ventricle) was
considered as one object, with temporal and occipital horns included in the analysis. This
implies a much more challenging shape to model. MDL and SPHARM gave worse results
when applied to the femoral head: the generalization error was between 7 and 3 mm for MDL
(8 and 4 mm for SPHARM), and the specificity error was between 5.2 and 4.6 mm for MDL
(slightly higher for SPHARM). Since we did not apply our method to the same datasets, it
is not our goal to claim better performances in respect of other approaches: the quantitative
comparison is useful to show that our method provides satisfactory results when applied
to medical structures characterized by challenging shapes. Moreover, our method reaches
comparable results on clinical T2 weighted images with a slice thickness of 3 mm. Most
of the reported work in the literature on brain structures was performed on high resolution
T1-weighted images (1mm isotropic).
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Table 2.7: Performances of the PDM for brain ventricles (aT = 0.025, average initial shape).
The table shows ranges (in mm) for reconstruction error, generalization error, and specificity
error.
Controls Alzheimer
Compactness 11 modes 15 modes
Reconstruction Error (mm) [1.1 - 2.3] [1.1 - 2.4]
Generalization Error (mm) [1.9 - 2.4] [2.1 - 2.5]
Specificity Error (mm) [5.8 - 7.5] [5 - 7]
2.5 Discussion
2.5.1 Method overview
GAMEs present some advantages when compared to previously published approaches for
shape modeling and analysis. Once the cloud of surface point is acquired, the unsupervised
clustering automatically detects areas in which more clusters (nodes) are needed: thus, we do
not need to iteratively reduce the set of original surface points to a subset with high (sparse)
dense point distribution in areas of high (low) curvature, as required in [22]. Differently from
methods based on spherical harmonics, GAMEs does not require a spherical topology for
the shapes to be parameterized; moreover, being based on node’s coordinates, changes in the
feature space are directly related to shape changes: thus, the interpretation of the results is
straightforward. SPHARM presents a multi-scale feature which we did not investigate in our
approach: nevertheless, it would be achievable by a progressive reduction in the accuracy
for the growing process (aT ). GAMEs can easily be extended to consider multiple objects
representation (as in M-reps). Each node in the mesh can be labeled differently depending on
which organ it represents (or which part of an organ, i.e. left- right-ventricle): the growing
neural network can then grow independently, and be considered as one in the PCA phase.
In [6], the authors highlight how critical some aspects are for the final model: the number
of nodes, their locations, and the correspondence across subjects strongly influence the final
performances. GAMEs are rooted in a pairwise framework: thus, the final model might be
influenced by the initial shape one starts with. Nevertheless, not having to deal with genetic
optimization, pairwise approaches require less computational time and are therefore more
suitable for learning systems: how do we improve our model when new shapes are available?
Groupwise approaches have to undertake the whole optimization process again.
2.5.2 Quantitative analysis on synthetic data
The experiments performed on synthetic data showed the reproducibility and robustness to
noise of our method. Both these aspects are important when dealing with real datasets, since
errors in image acquisition and occlusions are common in medical images. Landmarks detec-
tion is a desirable feature for PDMs: shape analysis would be meaningless if corresponding
nodes through models did not represent homologous structures. The good performances of
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Figure 2.8: Comparison between statistical model obtained using the Mahalanobis distance,
and one obtained without. Although not using the Mahalanobis distance leads to a more
compact model (7 modes instead of 11 to cover more than 90% of the total variation), both
the reconstruction and generalization errors are better when the Mahalanobis distance is used.
GAMEs proved to be very satisfactory for medical image analysis. The PDMs are used
to build up statistical models of shape variations. When tested on populations of synthetic
shapes, our method could highlight the right modes of variations with a high degree of com-
pactness: the error functions were below the acceptable error for medical image analysis re-
ported in other studies (see [8]). The capability of detecting local shape differences between
populations was also tested. On synthetic shapes we could correctly pinpoint the locations of
major differences between two populations of S Shaped tubes. Statistical maps with color-
coded p values were used to visually investigate local deformations. Our method performed
successfully in all the steps which characterize shape modeling and analysis processes.
2.5.3 Brain Ventricle Analysis
The analysis of brain ventricles went through the modeling of two populations: patients with
Alzheimer’s Disease, and age-matched controls. After having chosen the most suitable accu-
racy level, and having generated an initial average shape, we proceeded with the modeling of
all subjects. The PDM performances were assessed through the evaluation of compactness,
reconstruction error, generalization error, and specificity error. We compared our results
with other studies in the literature, and showed that GAMEs provide satisfactory results when
applied to challenging medical structures.
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Table 2.8: Formulae and values for variables in the unsupervised clustering and adapting
algorithms.
accT aT fT α β eT
0.001 0.025 1− 1α ∗ (1− e−α∗5/β) 1.05 3.33 for winner node 50
14.3 for neighbour node
2.6 Conclusions
We presented a new framework for shape modeling and analysis. Growing and Adaptive
MEshes (GAMEs) are used to model different instances of similar objects, addressing the
problem of point correspondence in a straightforward way. We have thoroughly evaluated
our algorithm on challenging synthetic shapes, and successfully applied it to the analysis of
brain ventricles in healthy elderly controls and patients subject to Alzheimer disease. Be-
cause of its generality, the GAMEs approach can easily be applied to the modeling of other
organs. To the best of our knowledge, GAME is the first attempt to merge two sound tech-
niques (SONGWR and SOM) to address the problem of shape modeling and analysis. In
future works we will investigate the modeling of multiple objects by growing several meshes
simultaneously. Moreover, intensity information could easily be integrated in the modeling
as fourth dimension, and different similarity measurements investigated.
2.7 Appendix 1
In this section we present the growing phase of GAMEs. The threshold values used in our
implementation are reported in Table 2.8: these values were also used in [11], except for the
threshold aT . Given a cloud of surface points Pi = {p1i , ..., pNi }, the unsupervised clustering
algorithm is given:
1. Initialization
2. Do
(a) Randomize order in Pi
(b) Cluster Pi
(c) Remove unused nodes
(d) Evaluate new accuracy
while accuracy is above a certain threshold accT
3. Evaluate covariance matrixes
4. Repeat loop 2 using Mahalanobis distance
5. Update covariance matrixes
35
CHAPTER 2
Following the terminology introduced in [11]:
1 Initialization: create the set of nodes A = {n1, n2}, with n1 and n2 randomly located in
the 3D space; create the set of connections among nodes (edges) C = ∅
2a Randomize: The sequence of surface points Pi is randomly re-sorted. This ensures a
homogeneous growth of the network at each step of the loop.
2b Cluster Pi
• This is the core of SONGWR ([11]), reported for clarity
• For each point pik ∈ Pi:
1. ∀ nq ∈ A evaluates ||pik − nq||, where || · || is the Euclidean distance in 3D
2. select the two best matching nodes s, t ∈ A as
s = argmin
n∈A
||n− pik||, t = arg min
n∈A−s
||n− pik|| (2.6)
3. create the connection between s and t C = C ∪{(s, t)} (if not present in C), and
set the age of the connection Ages,t = 0
4. evaluate the activation for s, a = e−||p
i
k−s||
5. if a < aT and fs < fT
– add a new node r, A = A ∪ {r}, with r = (s+ pik)/2
– add edges C = C ∪ {(r, s), (r, t)}, with Ager,s = 0, Ager,t = 0
– remove edge C = C − (s, t),
where aT and fT are thresholds, and fs is the firing value for node s (defined in
equation 2.8)
6. else
– adapt the positions of s and its neighbours
s = s+ ew ∗ fs ∗ (pik − s), ns = ns + en ∗ fk ∗ (pik − ns) (2.7)
where
0 < en < ew < 1, ns ∈ As, As ⊆ A is s’neighborhood,
en = 0.1 ∗ e−
d2
2∗σ2 , σ = 0.42, d = distance from s
ew = 0.1, (= en, with d = 0)
7. increase age of edges ending in s, Age(s,v) = Age(s,v) + 1, v ∈ As
8. decrease the firing value associated with s and its neighbors
fs = 1− 1
αw
∗ (1− e−αwt/βw), fn = 1− 1
αn
∗ (1− e−αnt/βn), (2.8)
where t is the number of times the given node has already been selected as s, or
as neighbour of s
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9. remove edges with Age(v,z) > eT
10. remove nodes without edges
2c Remove nodes which have never been selected as best matching in loop 2b
2d Evaluate Accuracy with which the model represents the surface points.
3 Evaluate Covariance: for each node in the model, find the subset of surface points which
has the node as best-matching node, and evaluate the covariance matrix associated with them.
4 Repeat Loop block 2 using everywhere the Mahalanobis distance for || · ||.
2.8 Appendix 2
In this section we give a brief overview on how nodes are adapted in Self-Organizing Maps
(SOM, [14]).
Each output node has an associated vector of dimensionality D, wi = (w1i , .., w
D
i ), i =
1..N . When an input vector x is given to the network, the output best matching node is
identified:
oi(x) = argmin
q∈O
||q − x||. (2.9)
Each nodes is then modified as follows:
wnewk = w
old
k + µ ∗ f(i, k) ∗ (x− woldk ), k = 1..N, (2.10)
where f(i, k) is the neighborhood function, and has value 1 when i = k and decreases with
the distance d(i, k) between node i and k in the array. An example of neighborhood function
is given by:
f(i, k) = exp−
d(i,k)2
2∗σ2 , (2.11)
where σ is the width parameter which can be decreased in time to assure convergence. Nodes
far from the best matching one are only slightly adapted; nearby nodes responds to similar
input and get similar updates, preserving topology.
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Shape Differences of The Brain Ventricles in Alzheimer’s
Disease
The Devil hath power to assume a pleasing shape.
William Shakespeare (Hamlet), 1564-1616.
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Abstract The brain ventricles are surrounded by gray and white matter structures that are
often affected in dementia in general, and Alzheimer’s disease (AD) in particular. Any change
of volume or shape occurring in these structures must affect the volume and shape of the
ventricles. It is well known that ventricular volume is significantly higher in AD patients
compared to age-matched healthy subjects. However, the large overlap between the two
volume distributions makes the measurement unsuitable as a biomarker of the disease. The
purpose of this work was to assess whether local shape differences of the ventricles can be
detected when comparing AD patients and controls. In this work, we captured the ventricle’s
shape and shape variations of 29 AD subjects and 25 age-matched controls, using a fully
automatic shape modeling technique. By applying permutation tests on every single node
of a mesh representation of the shapes, we identified local areas with significant differences.
About 22% of the ventricular surface was found to be significantly different (P < 0.05)
(∼14% of the left, and ∼7% of the right side). We found that in patients with Alzheimer
disease, not only the lateral horns were significantly affected, but also the areas adjacent to the
anterior corpus callosum, the splenium of the corpus callosum, the amygdala, the thalamus,
the tale of the caudate nuclei (especially the left one), and the head of the left caudate nucleus.
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3.1 Introduction
Alzheimer’s disease (AD) is the most common cause of dementia in middle-aged and older
adults. It is a progressive, irreversible, and degenerative brain disorder that causes impairment
in memory, thinking, and behavior. The vast emotional and economic costs of this disease
are continuously growing, as the population gets older. Although the risk of developing AD
increases with age, AD is by no means a part of the normal aging process. In the absence of
this disease, the human brain can often operate properly to the age of 100 and beyond.
The imaging-based measurements of disease progression in AD that have received the
most attention are MRI measures of the rate of change in whole-brain volume and hippocam-
pus volume [1–7]. Early studies showed that the brain volume decreases and cerebrospinal
fluid volume increases with advancing age. It has been shown in [8, 9] that different brain re-
gions lose volume at different rates in a non-linear region-dependent manner, with prefrontal
volume declining more rapidly than other brain regions [10, 11]. Different diseases with dif-
ferent phenotypic presentations may be associated with specific patterns of regional atrophy.
Studies in AD have shown prominent early involvement of medial temporal lobe structures,
especially the entorhinal cortex and the hippocampus [12–15].
In AD, there is increasing evidence of marked damage and dysfunction not only in the
gray matter but also in the white matter [16–18]. Neuropathological and biochemical studies
on white matter from AD subjects have demonstrated dramatic loss of myelin and axons
[5, 17]. Several studies have demonstrated that structural white matter changes, such as
atrophy of the corpus callosum, are significantly greater in AD than in healthy subjects [19–
21].
The brain ventricles (see Fig. 3.1) are in the center of the brain, surrounded by gray and
white matter structures that are often affected by dementia diseases: deep white matter, corpus
callosum, hippocampus, amygdala, caudate nucleus, and thalamus. Any change of volume or
shape occurring in these structures must affect the shape and volume of the ventricles.
It is well known that brain ventricle volume is significantly higher in AD patients com-
pared to age-matched healthy subjects. However, the distributions of volume measurements
of both groups present a large overlap, which makes the volume measurement not suitable as
a biomarker.
The purpose of this work was first to study the shape of the brain ventricles and their
Figure 3.1: The brain ventricles discussed in this paper follow the indications shown in this
image: left, right, anterior, and posterior are considered from the patient’s point of view.
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variations in healthy elderly and AD subjects, and second to investigate the presence of sig-
nificant shape differences between the two groups. The shape of brain ventricles is highly
concave and therefore challenging to model and analyze: it requires therefore sophisticated
computing techniques.
3.2 Methods
3.2.1 Subjects
Twenty-nine patients with probable AD (12 men, 17 women, mean age 73 years, age range
60.83 years) and 25 volunteers with normal cognitive function (11 men, 14 women, mean
age 74 years, age range 64.89 years) were included. The patients with probable AD had been
consecutively referred to our outpatient memory clinic. The volunteers had been recruited
through an advertisement in a local newspaper. All subjects were evaluated for memory loss
using a standardized dementia screening that included a detailed medical history, a general
internal and neurological exam, laboratory tests, neuropsychological testing including the
Mini Mental State Examination (MMSE), and magnetic resonance images (MRI) of the brain.
Of the 29 patients with probable AD, 2 patients were severely demented (MMSE < 10), 20
patients were moderately demented (9 < MMSE < 21), and 7 patients were mildly demented
(MMSE > 20). Diagnoses were made in a multidisciplinary consensus meeting according to
the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer’s
Disease and Related Disorders Association (NINCDS-ADRDA) criteria for probable AD.
Patients and controls were included if they (1) were older than 60 years, (2) had no other
neurologic or psychiatric illness, and (3) had no abnormalities on MRI other than white matter
hyperintensities or an incidental small lacunar lesion (> 5 mm diameter). The study was
approved by the local Medical Ethical Committee. Written informed consent was obtained
from all subjects or from a close relative if a patient was demented.
3.2.2 MRI acquisition and pre-processing
MRI was performed on a 1.5-T MR-system (Philips Medical Systems, Best, The Netherlands)
using the following pulse sequences: dual fast spin-echo (proton density and T2 weighted):
time to echo (TE) 27/120 ms, repetition time (TR) 3000 ms, 48 contiguous 3-mm slices
without an interslice gap, matrix 256 x 256, field of view (FOV) 220 mm. FLAIR (fluid
attenuated inversion recovery): TE 100 ms, TR 8000, 48 contiguous 3-mm slices without an
interslice gap, matrix 256 x 256, FOV 220 mm.
In-house developed automated segmentation software (SNIPER, Software for Neuro-
Image Processing in Experimental Research) that combines template-based fuzzy clustering,
fuzzy inference, and region-growing techniques was used to pre-process the images. Using
the method described in Admiraal-Behloul et al. [22], the software extracts fully automat-
ically the intracranial cavity, the cerebrospinal fluids (CSF), and the white matter hyperin-
tensities. The lateral and third ventricles were semiautomatically extracted by re-labeling
the wrongly segmented ventricular CSF to ventricles; this was done using interactive editing
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Figure 3.2: The shape modeling algorithm: unsupervised surface point clustering and adap-
tation phase.
tools: the user, by a simple click, re-labels pre-segmented CSF. The re-labeling has been done
slice-by-slice, using 2D region growing.
For shape modeling and statistical comparison purposes, all the images were corrected
for brain size and orientation by linear mapping into a stereotaxic space using an automatic
affine 12-parameters registration [23]. The LUMC T2-weighted brain template for geriatrics
was used as target image [24].
3.2.3 Statistical shape Modeling
The notion of biological shape seems reasonably well explained by a statistical description
over a large population of instances [25]. The model building requires, as a key step, the
establishing of correspondence between shape surfaces over a large set of training examples.
Finding correspondence between two surfaces implies finding corresponding elements that
share position and/or shape similarities. Finding the right way to define correspondent points
on different shapes is difficult. In some 2D application, manual landmark definition might be
possible, but it becomes unpractical when 3D shapes are considered due to the larger amount
of data. In 3D, the manual landmark definition is time consuming, poorly reproducible, and
error prone. The problem can be summarized in 3 main questions: How many landmarks or
nodes (in mesh representation) are needed?, Where should they be located?, and How can
one define node correspondence across several instances of shapes?
In a previous work [26], we showed how to use growing neural networks to answer all
three questions. Most of the growing neural networks are variations of the growing cell
structure (GCS) introduced by Fritzke [27]. Marsland presented a Self- Organizing Network
That Grows When Required (SONGWR) [28]. SONGWRs proved to be (1) more data driven
while growing and (2) faster in learning input representation when compared with previous
models.
In a SONGWR, each node is associated with a subspace of the input space. The network is
initialized with few nodes randomly located in the input space and not connected together. At
each iteration, a new input is given to the network; in order to maintain a good representation
of the input space, the existing nodes are moved or removed (adaptation), or new nodes and
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Figure 3.3: PCA performances for statistical modeling of the ventricular shapes in the control
group. The plots show how the performances change depending on the total number of modes
of variation being considered (horizontal axis). Increasing the accuracy from 0.025 to 0.05
does not improve the model significantly. Using an average shape is generally better than
using a good representative from the data set.
connections are added to the network (growing) (see Fig. 3.2). The process is repeated until
convergence: a final model of the input space (at a desired accuracy level) is reached. The
SONGWR principle is based on self-organizing maps (SOM) [29], which are known to be
perfectly topology-preserving: the network preserves neighborhood relations in the data by
mapping neighboring inputs onto neighboring nodes in the map.
In case of shape modeling, the input space of the neural network is the whole set of sur-
face points extracted from the object to be modeled (i.e., extracted from segmented brain
ventricles). A representative instance of the shape is used as input for the growing and adapt-
ing iterative algorithm. Once the SONGWR algorithm has converged, the optimal number of
nodes and their spatial locations are identified. The next step is to find corresponding nodes
across different instances of the shape to be modeled. At this stage, only the adaptation part
of the SONGWR algorithm is used. Adapting the network to a new instance is equivalent
to using the model as a classifier: for each given point in the new shape instance, the best-
matching node is selected (as the closest to the given input according to a predefined distance
function) and adapted accordingly. The process has similarity with SOMs because there are
no added/removed nodes anymore (note that the shape instances must be normalized before
modeling). After adapting the initial mesh to all other instances of the data set individually,
every node of the initial mesh will have a corresponding cloud of matching nodes across the
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Figure 3.4: PCA performances for statistical modeling of the ventricular shapes in the
Alzheimer’s disease group. The plots show how the performances change depending on
the total number of modes of variation being considered (horizontal axis). The results are
comparable to the modeling of the control group shown in Fig. 3.3.
data set.
The aim of this work is to investigate local differences between two populations of shapes.
It is therefore important that the models (meshes) used to describe the objects are sensitive to
shape differences across individuals. In this respect, we followed the approach described by
Davies et al. [30] to evaluate the obtained mesh representation.
A mesh is composed of N nodes, where each node is characterized by three coordinates
in the 3-dimensional space. Thus, each mesh is a 3 x N -dimensional object x in the feature
space. Given a set of meshes, one can carry out a principal component analysis (PCA) to get
a mean mesh and main eigen variations.
The performances of the resulting statistical model can be evaluated using the following
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functions:
C(M) =
M∑
m=1
pm (3.1)
Er(M) =
1
Ns
Ns∑
i=1
|SNsi (M)− Si| (3.2)
G(M) =
1
Ns
Ns∑
i=1
|SNs−1i (M)− Si| (3.3)
Sp(M) =
1
N
N∑
i=1
Diss(Si(M), {ST1 , ..., STNs}) (3.4)
Diss(Si(M), {ST1 , ..., STNs}) =
1
Ns
Ns∑
i=1
|STi (M)− Si(M)|, (3.5)
where:
• Compactness C(M): the percentage of variance in the data set that is covered by the
first M modes of variation (where Pm is the percentage of total variation covered by
the mth mode). A better model requires a smaller number of modes to cover the same
amount of variance.
• Reconstruction error Er(M): the average accuracy in approximating the Ns shapes
of the training set using M modes. Si is the original shape whereas SNSi (M) is its
approximation through a model based on all the Ns shapes. This function shows how
good the model is in reconstructing the shapes seen in the training set.
• Generalization error G(M): for a given i, the shape Si is approximated by a model
generated with all the other shapes. The approximation is indicated as SNS−1i (M);
this function shows how good the model is in generalizing what it has learnt from a
training set, working on an unseen shape.
• Specificity error Sp(M) is evaluated by uniformly samplingN = 100 instances Si(M)
of the object class according to the model, and averaging the dissimilarity between
them and the shapes in the training set STi . This function measures the similarity
between the training set and the shapes one can create through the model.
There are mainly two factors that can strongly influence the performances of the final
statistical model: the choice of the first shape-instance to be used to build the first mesh rep-
resentation [31], and the accuracy threshold aT [28] that defines how accurate the first model
should be in approximating the corresponding object. In this study, we have experimented
with these two factors and chosen the best statistical model according to Eqs. 3.1-3.5.
The PCA approach described in this section is used mainly to identify global variations
within each population and to estimate the performances with which the growing and adapt-
ing phases model the given shapes. An independent component analysis (ICA) approach
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could be used to highlight local variations within a population [32], but this lies outside the
scope of this work.
3.2.4 Surface-based statistical comparison
The highlighting of local shape differences between populations is possible because each
node in the first model is uniquely labeled; it is thus possible to follow the node position to
find corresponding points within each population and across populations.
When comparing two populations, several statistical tests can be used. Permutation tests
have been successfully applied to the analysis of brain images [2, 33]; they require limited as-
sumptions and provide correct results for multi-test analysis when local information is needed
(i.e., local surface comparison of two or more groups).
Given two populations G1 and G2, the question one tries to answer is: are the shapes
in G1 significantly different from those in G2? Moreover, if such a global difference exists,
can one localize the most different areas on the surface? In the feature space, these questions
translate as: ”are G1 and G2 separable?”, and ”which feature set leads to the best separabil-
ity?”.
The permutation tests provide us with a P value for the omnibus hypothesis ”the two
groups G1 and G2 are drawn from the same population”. Moreover, we obtain the P values
for each node in the model, showing whether the distribution of that node in space is the same
in G1 and G2 or not. Permutation tests can be summarized as follows:
1. Considering two groups G1 and G2:
(a) Each node in the average model has two corresponding clouds of points C1 and
C2, obtained considering the positions the corresponding nodes assume through
all the shapes in G1 and G2.
(b) C1 and C2 are compared via a Hotelling’s T2 statistical test; the outcome of the
test is the t value for the node comparison (are the node positions distributed in
C1 and C2 in significantly different ways?).
2. For 10,000 times, two groups of shapes A and B are built up by randomly mixing G1
and G2, and point 1 is performed on them. Only the highest t value is stored for each
iteration.
3. A critical t value tc is evaluated as the kth highest value of all the 10,000 t values
previously stored (plus the tmax for the original subdivision in G1 G2), where
k = bα ∗ 10, 000c+ 1, α = 0.05. (3.6)
4. The P value for the omnibus hypothesis ”G1 and G2 are the same” is evaluated as
Pvalue =
N
Ntest
, where (3.7)
N = {stored tvalues|tvalue > tc}, (3.8)
Ntests = 10, 000 + 1. (3.9)
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Figure 3.5: Tensor-based representation of the nodes within controls (left column) and AD
patients (right column). Each tensor is color-coded according to the direction of the main
eigenvector: green for the anterior-posterior direction, blue for the inferior-superior direction,
and red for the left right direction.
5. Finally, point 4 is applied to each single node, counting how many t values are higher
than the t value associated with a particular node in the original G1 G2 grouping of
shapes, and dividing the number for 10000 + 1; this leads to a P value (corrected for
multi-tests) for each node in the model.
3.3 Results
3.3.1 Optimal shape modeling parameters
In order to find the most suitable statistical model, we experimented with different threshold
aT and different initial shapes. As threshold level, we compared 0.01, 0.025, and 0.05.
Concerning the initial shape, we considered a single case randomly selected out of the control
population, and the average ventricle of the control population.
Results for compactness, reconstruction error, generalization error, and specificity error,
obtained for the modeling of the ventricular shapes of the control group, are shown in Fig.
3.3. Those obtained for the AD group are given in Fig. 3.4. Table 3.1 shows the number of
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Figure 3.6: Color-coded maps showing the P value associated with each node while compar-
ing controls and AD patients. The P values were evaluated at α = 0.05.
nodes and an indication of the adaptation time for different thresholds (average of controls
used as initial shape).
When an average initial shape was used we achieved slightly better results than with an
individual initial shape (at the same aT threshold). Moreover, the performances improved
while increasing the accuracy: aT = 0.025 and aT = 0.05 gave significantly better results
than aT = 0.01, whereas the difference between 0.025 and 0.05 was not relevant. Finally, the
choice between an average- and individual initial shape did not seem to influence the final
results relevantly. In order to keep a low computational load (see Table 3.1), we used aT =
0.025, in combination with an average initial shape, for the rest of the experiments.
3.3.2 Tensor maps for groups representation of global and local varia-
tions
Given a node in the model, we considered the cloud of locations the node assumed moving
through matched nodes in the population: computing the covariance matrix associated with
the cloud and its eigenvectors allows us to generate a tensor representation of the node (see
Fig. 3.5). Each ellipsoid represents the distribution in space of a particular node while moving
across individuals belonging to the same group. The size of the ellipsoids is proportional to
Table 3.1: Computation load for different thresholds: we report the number of nodes of the
final model and the time needed to adapt the model to a new shape.
No. of ndoes Adaptation time
(in minutes, per shape)
aT = 0.01 337 2 ± 1
aT = 0.025 844 6 ± 2
aT = 0.05 1689 16 ± 4
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Table 3.2: Number of nodes in the model and percentage of surface area found to be sig-
nificantly different at 95% and 99% of confidence interval (LV = left ventricle, RV = right
ventricle).
No. of nodes % Total Area No. nodes % No. nodes %
LV LV RV RV
α = 0.05 183 22 121 14 62 7
α = 0.01 80 9 55 7 25 3
the eigenvalues of the tensor, whereas the color-coding maps the direction in space of the
main eigenvector.
Most of the tensors present a first (main) mode of variation perpendicular to the surface
rather than along the surface. Variations along the surface are generally a consequence of
misplacement in adaptation (i.e., corresponding nodes that do not represent similar anatomi-
cal locations) or registration errors (i.e., small errors due to incorrect transformation matrix).
Perpendicular variations are more likely to reflect real variations in shape because the nodes
are always forced to be on the surface. Intuitively, the more perpendicular to the surface
the tensor is, the better the node can capture the variations within a population and across
populations. One can notice that the main modes of variation in both groups are the global
dilation/shrinking of the ventricles and the elongation/contraction of the temporal horns.
The most striking results are the asymmetrical variations (left vs. right) between the
inferior temporal horns within healthy controls as well as in the AD group. Note that in the
control group, the left inferior horn presents mainly inferior-superior thickening variations
(blue) whereas the right inferior horn shows elongation variations in the anterior-posterior
direction (green).
Both left and right horns are showing more pronounced variations (according to the sizes
of the ellipsoids) within the AD group compared to the controls. In AD, the variations are
also asymmetrical but different from those seen in controls: the right inferior horn is showing
inferior-superior widening (blue) whereas the left horn is showing mainly an enlargement
in all directions; the tensors are almost isotropic (spherical). The color code, based on the
value of the largest eigen value, shows a slight elongation tendency in the posterior-anterior
direction (green) and a widening in left-right direction (red).
3.3.3 Statistical shape comparison of AD vs. controls using statistical
maps
For each node, the P values derived from the permutation tests have been color-coded and
mapped on an average model of the brain ventricles (see Fig. 3.6). Table 3.2 gives the per-
centage of area found to be significantly different at α = 0.05 and α = 0.01. Figure 3.6 shows
significant differences on the inferior lateral horns (left and right) and the areas adjacent to
the left side of the splenium of the corpus callosum, a midsagittal area of the corpus callosum,
the amygdala (left and right), the tale of the caudate nuclei (especially the left one), the head
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of the left caudate nucleus, and some areas adjacent to the thalamus (on the third ventricle).
A total area covering 22% of brain ventricular surface was significantly different with
P < 0.05 and 9% of total brain ventricles presented significance at P < 0.01. The left
lateral ventricle presented more significant differences (14% of the total surface at P < 0.05)
as compared to the right ventricle (7%, P < 0.05).
3.3.4 Local shape comparison using displacement maps
Once the local area presenting the most significant local shape differences were identified, we
computed the displacement vectors that would move a node from an average control shape
to an average AD shape. Figure 3.7 shows the directions of the displacement vectors for the
significantly different nodes (P < 0.05). The length of the vectors is color-coded and mapped
on the surface. In Fig. 3.8, we show both the main direction of normal variations (derived
from the control group) and the directions of the control-to- Alzheimer transformation of
Fig. 3.7. For most nodes, the direction control to Alzheimer is clearly not along (parallel)
the normal variations (in control group); this confirms the significance of the local shape
differences.
3.4 Discussion
The hippocampus and the corpus callosum are frequently studied structures in AD [6, 21,
34–43]. Some other structures such as the lateral ventricular horns have also attracted the
attention of researchers [33, 35, 44]. Thompson et al. [33] presented a longitudinal study
to analyze the hippocampal and ventricular changes in AD. An anatomical surface modeling
approach was combined with surface-based statistics to visualize the regions of significant
shape differences between the two groups at both base line and follow-up scans as well as
rate of atrophy in the serial MRI scans. They concluded that although both temporal horns
and hippocampus maps correlated with clinical deterioration, temporal horn expansion maps
were more sensitive to AD progression. In this paper, we extended the cross-sectional part of
the analysis to the whole cerebral ventricular system (with the exception of the 4th ventricle)
motivated by the fact that many adjacent brain structures are affected by dementia in general
and AD in particular. Any change of shape and/or volume of the surrounding structure is
directly reflected in the shape and volume of the ventricles.
Segmenting brain structures, such as the hippocampus, is tedious, time consuming, and
often imprecise because most of these structures are relatively small and often do not present
sufficient contrast or sharp borders. Furthermore, the white/gray matter image contrast in the
elderly is considerably reduced as compared to young individuals, making any delineation
(automatic or manual) a quite difficult and unreliable task. However, the contrast between
CSF and the parenchyma remains sharp, thanks to clear CSF image intensity, irrespective of
age. Therefore, the brain ventricle delineation is easier and more reliable.
Although the brain ventricles are relatively easy to delineate, their complex 3D shape is
challenging to model and analyze. In this paper, we applied a fully automatic technique that
is based on growing neural networks [26]. A first mesh model is generated on the average
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Figure 3.7: Local changes required to transform an average control shape into an average AD
shape. The direction of movement is indicated by the arrows; the amplitude of movement is
color coded.
brain ventricles of the control group using the unsupervised growing phase of the algorithm.
After convergence, the shape is adapted to every instance of the data set (healthy and AD
subjects). The point correspondence is automatically established during the adaptation phase
(automatic deformation) of the mesh.
We performed permutation tests for every node of the mesh and mapped the correspond-
ing P values with a color code to highlight the local areas with significant differences (Fig.
3.6). For these areas, we computed the displacement vectors that would move a node from
an average control shape to an average AD shape (Figs. 3.7 and 3.8).
Our results show that in patients with AD, not only the lateral horns were significantly
affected by the disease, but also the areas adjacent to the anterior corpus callosum, the sple-
nium of the corpus callosum, the amygdala, the thalamus, the tale of the caudate nuclei, and
the head of the left caudate nucleus.
Although most of the analysis on brain morphology in AD are performed on high-resolution
T1-weighted images, the MR images used in this work are quite standard in clinical settings
(T2- weighted and FLAIR, 3 mm slice thickness). When scan time is not an issue, it is ob-
viously preferable to acquire high-resolution images for morphology analysis. It would be
therefore beneficial to run our experiments on higher resolution images and compare the ex-
tent of the areas showing significant differences. On the other hand, our work shows that
even on relatively low-resolution images, shape differences can be picked up when studying
the brain ventricles.
To our knowledge, this is the first study to report on local shape differences of the whole
cerebral ventricular system in AD patients. The most widely used biomarker for AD is the
volume of the hippocampus. However, the hippocampal atrophy occurs also in other demen-
tias [43]. In our preliminary study, we observed that apart from shape changes in the tem-
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Figure 3.8: Local changes required to transform an average control shape into an average
AD shape (red arrows) compared with the main direction of variation within controls (white
arrows). The images show the right and left temporal horns (a)-(b), and the frontal part of
the left lateral ventricle (c). Note that the arrows are not parallel, indicating different shape
changes between the two groups.
poral horn, reflecting hippocampal atrophy, other brain parts of the ventricles also showed
differences in shape when comparing AD patients and controls. Whether these additional
ventricular shape changes permit superior differentiation of AD patients and patients with
other neuro-degenerative conditions should be subject to further research.
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Ventricular Shape Biomarkers for Alzheimer’s Disease in
Clinical MR Images
Better to add life to our days, than days to our lives
(Meglio aggiungere vita ai giorni, che giorni alla vita).
Rita Levi Montalcini, 1909- .
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Abstract Aim of our work was to identify ventricular shape-based biomarkers in Magnetic
Resonance (MR) images to discriminate between patients with Alzheimer Disease (AD) and
healthy elderly. Clinical MR images were collected for 58 patients and 28 age-matched
healthy controls. After normalizing all the images, the ventricular cerebrospinal fluid was
semi-automatically extracted for each subject and an innovative technique for fully automatic
shape modeling was applied to generate comparable meshes of all ventricles. The search of
potential biomarkers was carried out with repeated permutation tests. Results highlighted
well-defined areas of the ventricular surface as being discriminating features for AD: the
left inferior medial temporal horn, the right medial temporal horn (superior and inferior),
and the areas close to the left anterior part of the corpus callosum and the head of the right
caudate nucleus. The biomarkers were then used as features to build an intelligent machine
for AD detection: a Support Vector Machine was trained on AD and healthy subjects, and
subsequently tested with leave-1-out experiments and validation tests on previously unseen
cases. Results showed a sensitivity of 76% for AD, with an overall accuracy of 84%, proving
that suitable biomarkers for AD can be detected in clinical MR images.
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4.1 Introduction
Alzheimer’s Disease (AD) is commonly recognized as the most common form of dementia
in elderly. Due to an increased life expectancy and a high conversion rate in elderly [1], the
emotional and economic costs of AD are continuously growing. Treatment strategies for AD
have proved more successful if administered during the early stages of the disease [1]: thus,
biomarkers for early diagnosis of AD are highly desirable.
Attempts to detect biomarkers have been previously presented in the literature. Hans-
son et al. [1] investigated different proteins, and proved how their concentrations in Cere-
broSpinal Fluid (CSF) can be correlated with the progression of AD: the CSF samples were
acquired with lumbar punctures, a highly invasive procedure. Leon et al. [2] stated that vol-
umetric changes of hippocampal atrophy and medial temporal atrophy, although associated
with AD progression, are not specific for AD: therefore, they suggested to combine neuro-
imaging techniques (Magnetic Resonance Imaging (MRI) and Fluorodeoxyglocose-Positron
Emission Tomography (FDG-PET)) with CSF biomarkers for a more sensitive early detection
of AD in both cognitively normal subjects and in patients with Mild Cognitive Impairment
(MCI). Even in this case, the need for CSF biomarkers implies an invasive procedure. Finally,
Kantarci et al. [3] tackled the problem of noninvasive techniques, providing an overview of
quantitative MR measurements which can help assessing the progression from a normal el-
derly to AD, passing through the MCI state. Particularly interesting is their conclusion on
how different subcortical structures undergo atrophy during the progression of the disease:
hippocampal atrophy develops rapidly in the early stage, and tends to slow down even before
AD is diagnosed; temporal lobe atrophy is more characteristic of the MCI to AD conversion,
while frontal lobe atrophy is characteristic of the last AD phase.
Clinical MR images of the brain can be easily obtained nowadays, and provide detailed
insights on brain structures in a noninvasive way. Challenging questions arise from these in-
sights. Are there markers in clinical images which characterize AD? Where are they located?
How sensitive are they in discriminating AD from healthy subjects? Alzheimer Disease is
known to cause atrophy in periventricular structures; a rational choice would therefore be to
analyze shape and volume changes in these areas, with shape changes being generally more
accurate than volume changes. Shape changes of hippocampus and ventricles have been as-
sociated with AD progression [4, 5]. Unfortunately, the contrast between white and gray
matter tends to decrease with age, making it difficult to correctly delineate periventricular
gray matter structures from their white matter surroundings in elderly. On the other hand,
the contrast between CSF and brain parenchyma remains mostly unaffected: thus, the anal-
ysis of ventricular shape changes is more reliable. As an example, in [6] the authors studied
ventricular shape differences to successfully discriminate healthy subjects and patients with
schizophrenia.
In this work, we focus on ventricular shape-based biomarkers for AD detection. Volume
and shape changes in periventricular structures are reflected on the volume and shape of the
brain ventricles: thus, by localizing differences in the ventricles, one can draw conclusions
about which periventricular structures are mostly affected by the disease. In previous works,
we introduced a new method for shape modeling and analysis, Growing and Adaptive MEshes
(GAMEs) [7], and applied it to the analysis of brain ventricular shapes in populations of
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healthy elderly and patients with AD [8]. In this study, GAMEs and repeated permutation
tests are used to prove the existence of well-defined ventricular areas which consistently
discriminate AD subjects from healthy elderly, showing the suitability of clinical MR for AD
detection. After detecting such biomarkers, these features will be used to train a Support
Vector Machine (SVM): by assessing the accuracy, generalization, and sensitivity properties
of the SVM, the feasibility of an intelligent machine able to detect AD from clinical MR
images will be demonstrated.
4.2 Material and Method
4.2.1 Subjects and MRI acquisition
Fifty-eight patients with probable AD (27 men, mean age 74 years, age range 60- 95 years),
and 28 volunteers with normal cognitive functions (12 men, mean age 74 years, age range 64-
89 years) were included in the study. The patients with probable AD had been consecutively
referred to our outpatient memory clinic. Volunteers were recruited through advertisements in
local newspapers. All subjects were evaluated for memory loss using a standardized dementia
screening including a detailed medical history, a general internal and neurological exam,
laboratory tests, neuropsychological testing including the Mini Mental State Examination
(MMSE), and MRIs of the brain. Diagnoses were made in a multidisciplinary consensus
meeting based on the National Institute of Neurological and Communicative Disorders and
Stroke-Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria
for probable AD. Patients and controls were included if they: were older than 60 years,
had no other neurologic or psychiatric illness, and had no abnormalities on MRI other than
white matter hyperintensities or an incidental small lacunar lesion (≤5 mm diameter). The
study was approved by the local Medical Ethical Committee. Written informed consent was
obtained from all subjects or from a close relative if a patient was demented.
MRI was performed on a 1.5-T MR-system (Philips Medical Systems, Best, The Nether-
lands) using the following pulse sequences: dual fast spin-echo (proton density and T2
weighted): time to echo (TE) 27/120 ms, repetition time (TR) 3000 ms, 48 contiguous 3-
mm slices without an interslice gap, matrix 256 x 256, field of view (FOV) 220 mm. FLAIR
(fluid attenuated inversion recovery): TE 100 ms, TR 8000, 48 contiguous 3-mm slices with-
out interslice gap, matrix 256 x 256, FOV 220 mm.
4.2.2 Pre-processing steps
In-house developed software for automatic-segmentation (SNIPER, Software for Neuro-Image
Processing in Experimental Research [9]) was used to pre-process the images: the software
extracted fully automatically the intracranial cavity, the CSF, and the white matter hyperin-
tensities. Interactive 3D tools based on region growing allowed the re-labeling of ventricular
CSF as ventricles. From each ventricular volume, the surface was extracted (see Fig. 4.1.a).
Before analyzing shape differences between populations, normalization is needed to correct
for brain-size and orientation. All images were automatically registered into a stereotaxic
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(a) (b)
Figure 4.1: (a) The ventricular CSF is extracted semi-automatically, and the ventricle surface
is reconstructed from the volume. (b) An affine 12-parameters registration brings all the
original images (first row) into a common stereotaxic space, removing differences due to
brain-size and orientation (second row, example given on T1 images).
space, the LUMC T2-weighted brain template for geriatrics [10], using automatic affine 12-
parameters image registration [11] (see Fig. 4.1.b). The same procedure was applied to the
segmented ventricular CSF.
4.2.3 Shape Modeling and Analysis
The local analysis of shape differences between two populations requires, as a first step, the
modeling of all the instances’ shapes. For this purpose, we used the GAMEs method de-
scribed in [7], and summarized in Fig. 4.2. An average shape is created from the control
population: a voxel-count map is built up by adding all controls’ binary volumes; subse-
quently, a threshold is applied to the voxel-count map, obtaining an average control ventricle.
During the first step of GAMEs, a mesh grows (adding nodes and edges) until it converges
to a good representation of the average control shape. Once the first mesh is obtained, the
number of nodes and edges is frozen. In a second phase, the mesh is adapted to all the in-
stances in the two populations using the Kohonen self-organizing map algorithm [12] (see
Fig. 4.3). Since nodes are not added nor removed, all the final meshes are comparable: each
node in a given mesh is uniquely associated with another node in another mesh, allowing
comparison between meshes. Comparable meshes are necessary for shape analysis, but not
sufficient: corresponding nodes in comparable meshes have to be representative of similar
anatomical locations. A thorough analysis of our method was performed in [7, 8], following
the suggestions given by Davies et al. [13, 14]: GAMEs proved successful in terms of re-
construction error, generalization error, compactness, specificity error, as well as in detecting
similar anatomical landmarks and highlighting local shape differences between populations.
Local shape differences between controls and AD were investigated in [8]: for each node
in the meshes, permutation tests were applied, resulting in a p-value indicating the probability
that the local shape in the two populations was drawn from the same distribution in space.
A p-value lower than 0.05 indicated that, at a confidence level of 95%, the local shape was
significantly different between controls and ADs. Since permutation tests were applied to
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Figure 4.2: GAMEs approach: (1) an average shape is built up from the Control population;
(2) through an unsupervised clustering algorithm, a mesh grows and adapts to model the
average shape; (3) the mesh is adapted to all the controls and AD shapes, without adding nor
removing nodes.
Figure 4.3: A mesh is adapted to a new instance in the population to represent the ventricular
surface.
all the subjects in the two groups, the ventricular regions highlighted in [8] were considered
characteristics for AD in those particular datasets. In this work, we expand the AD dataset,
and perform repeated permutation tests on randomly sub-sampled AD groups: thus, regions
consistently highlighted through the iterations can be safely considered as representative of
the pathology (AD).
When applied to the subjects of this study, our method provided us with 86 meshes (28
Controls and 58 AD) of 949 nodes: thus, each ventricle is a point in a feature space of
dimension 3 x 949 (three coordinates for each node). After detecting proper biomarkers, the
dimensionality can be reduced, simplifying the training of a classifier.
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Figure 4.4: (a) Biomarker Selection: Permutation Tests (PT) can be used to determine a
feature set discriminating between Controls and AD. In order to assess the consistency of
the results, PT were run several times and a consistency index was evaluated for each node.
(b) Design of the SVM: training and testing. After randomly splitting the AD group in two
sub-groups, the SVM is trained on Controls/AD1 and tested on other dataset combinations.
4.2.4 Biomarker Selection
Our first goal was to detect consistent biomarkers for AD. An elegant guess is to start with
those nodes (i.e. areas) highlighted as significantly different by permutation tests. A proper
biomarker set must reflect differences due to the disease, rather than a casual pattern due
to the particular subjects included in the study. In order to guarantee the consistency of the
nodes highlighted by the permutation tests, we set up the following experiment (schematically
represented in Fig. 4.4.a):
1. For Niter = 10 times, randomly select 50% of ADs to generate an AD1 group. Run
permutation tests on Controls-AD1, generating Niter P-value maps;
2. In the final matrix, each row is associated with a node in the mesh, while each column
reports the corresponding p-value for a particular iteration;
3. In each iteration (column), a node is considered significantly different between Con-
trols and AD if:
• its p ≤ Pthr or
• one of its neighbors (up to 2 links away in the mesh) had p ≤ Pthr;
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4. For each node (row), evaluate the percentage of iterations in which it was significantly
different (Consistency Index);
5. Finally, for each node (row) assess the median of all the p-values through the Niter
iterations.
If nodes highlighted as significantly different by permutation tests are actually discriminating
subjects depending on their healthy/AD condition, their p-values should not be affected by
the random sub-sampling through the Niter iterations. Therefore, a given node should be
either significantly different or not significantly different in most of the iterations: we define
such a node (characterized by a consistency index either lower than 20% or higher than 80%)
as a consistent node. Within the consistent nodes, we define as biomarkers those which
are significantly different between Controls and ADs. Depending on the Pthr threshold, the
amount of consistent nodes and biomarkers will change: ideally, one aims at having a high
percentage of consistent nodes, with a low percentage of biomarker nodes (fewer biomarker
nodes will lead to a smaller feature space in which training the classifier).
Different Pthr thresholds were used (0.05, 0.01, and 0.001) to assess the best set of shape-
based biomarkers. Results (reported in Table 4.1 and presented in section 4.3.1) led us to two
consistent sets. It is important to notice that the consistency of almost the entire ventricular
surface through the iterations (obtained with Pthr set to 0.01 and 0.001) proves the indepen-
dence of the biomarker sets (i.e. feature sets) from the particular sub-groups used to generate
these: regardless how AD is sub-sampled, similar locations are identified as biomarkers.
4.2.5 AD Detection with SVM
The second goal of this study was to use the biomarker sets to build an intelligent machine
(i.e. classifier) for AD detection in clinical MR images. During a supervised training phase,
the classifier learns how to discriminate between healthy subjects and ADs; subsequently,
new subjects can be classified by the machine. Important properties for a classifier are:
• Accuracy (Separability in the feature space): successful classification rate while clas-
sifying the objects of the training set;
Table 4.1: Consistent nodes and Biomarker nodes. For three different Pthr thresholds, we
evaluated the amount of consistent nodes and biomarker nodes (consistent nodes which are
significantly different).
% of Consistent Nodes % of Biomarker Nodes
p ≤ 0.05 70% 42%
p ≤ 0.01 80% 14%
p ≤ 0.001 90% 4%
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• Generalization: successful classification rate while classifying subjects previously not
used in the training phase (assessable with leave-1-out tests);
• Sensitivity and Specificity: successful classification rate while classifying previously
unseen ADs and Controls respectively.
SVM’s Description
A Support Vector Machine (SVM) is a well-known pattern recognition tool for data clas-
sification [15, 16]. Given a training set of l data-labels pairs {(x1, y1), ..., (xl, yl)}, with
xi ∈ Rn (e.g., a subject in our populations), and yi ∈ {−1, 1} (e.g., the healthy/AD status),
the SVM seeks for a hyperplane which separates the datasets, minimizing the classification
error. When a perfect separation of the training set can not be found, the SVM seeks for a
sub-optimal solution which allows misclassifications of some subjects xi in the training set:
the misclassifications are weighted by a positive constant term C > 0. After training, a SVM
can be considered as a decision-box which accepts a given subject xi, and associates it to the
corresponding status.
Linearly separation of the training set in the original input space might not provide the
desired results: thus, non-linear solutions might be necessary. Non-linear classifiers use a
kernel function of the data K(xi,xj) to transform the input space into a high-dimensional
space in which the desired hyperplane can be found: the resulting hyperplane in the trans-
formed space will translate into a non-linear classifier in the original space. We implemented
the Radial Basis Functions (RBFs) kernel, defined as:
K(xi,xj) = exp(−γ||xi − xj||2), γ > 0. (4.1)
Thus, the SVM is fully characterized by the two parameters C and γ, tuned during the train-
ing phase (see Appendix 4.5 for more details). A non-linear classifier might be more prone
to over-fitting, especially when trained on a limited number of examples: therefore, we ex-
perimented also with a linear SVM. Since the linear classifier did not present any significant
improvement (see Appendix 4.5), in the remainder of the paper we focus only on the RBFs-
based classifier. A more complete overview of the SVM’s mathematical background can be
found in [17].
SVM’s Training and Testing
Given a certain feature set (i.e. biomarker set), each mesh in the dataset can be represented by
a subset of its nodes in a high-dimensional feature space. The next step is to train a SVM to
discriminate between Controls and ADs: better feature sets will lead to a more discriminative
classifier. The procedure for training and testing is schematically reported in Fig. 4.4.b, and
follows the suggestions of Hsu et al.: A Practical Guide to Support Vector Classification
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(citeseer.ist.psu.edu/689242.html)1. After properly scaling the data2, we:
1. randomly split the AD group into two equally-sized groups: AD1 and AD2;
2. apply permutation tests on Controls vs. AD1 to detect the features associated with a
given Ptrh;
3. build up a training set Tr Set with Controls and AD1 (using the feature sets of point 2);
4. train and tune the SVM on Tr Set;
5. assess the SVM’s accuracy on Controls-AD1;
6. assess the SVM’s generalization property (leave-1-out experiment on Controls-AD1);
7. assess the SVM’s sensitivity on AD2.
The training and testing was performed for Pthr = 0.01 and Pthr = 0.001. Results are
reported in Table 4.2 and presented in section 4.3.2. It is worth commenting on point 2
of the training and testing procedure. After splitting the AD group in AD1 and AD2, we
apply permutation tests on Controls and AD1 to identify the appropriate feature set. Two
critics could be made to this step. One could argue that using the Controls and AD1 both
for feature selection and for the assessment of accuracy and generalization properties might
bias the results: nevertheless, following the method presented in section 4.2.4 and the results
of section 4.3.1, one can conclude that for Pthr = 0.01 and Pthr = 0.001 the biomarker
sets are consistent regardless of the sub-sampled AD group. Thus, the bias on the results, if
any, would be minimal. Considering this, one could argue that it is not necessary to perform
permutation tests again and that we could use the results of the repeated permutation tests of
section 4.2.4. Although this is true, we still prefer to avoid any potential minimal bias while
1All the experiments were performed using the libsvm library (Chang et al., LIBSVM: a Library for Support
Vector Machines: http://www.csie.ntu.edu.tw/ cjlin/papers/libsvm.pdf ) in MatLab 7.0.1.
2Scaling data is highly recommended. Features ranging over large numeric domains might dominate over those
presenting smaller range: linearly scaling all the features in a prefixed interval, e.g. [−1, 1], might help preventing
this problem.
Table 4.2: Performances of the SVM-RBFs: results show the separability in the future space
(i.e. Accuracy, evaluated on Controls-AD1), the generalization capability (leave-1-out experi-
ment on Controls-AD1) reported as Success-Rate (Specificity/Sensitivity), and the sensitivity
on unseen pathological cases (AD2).
Separability in the Generalization Sensitivity
Feature Space (Specificity/Sensitivity) (unseen dataset)
p ≤ 0.01 100% 88% (89% / 86%) 66%
p ≤ 0.001 93% 84% (82% / 86%) 76%
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Figure 4.5: The color-coded map shows, for each location, the median p value evaluated over
the Niter runs (p > 0.01 are shown in blue). The corresponding colored Figure can be found
at page viii, before the Introduction.
evaluating the sensitivity on AD2, since the detection of AD (sensitivity) has the highest
priority within this work (more details can be found in the Appendix 4.5).
4.3 Results
4.3.1 AD Biomarkers
Results for biomarker selection with repeated permutation tests are reported in Table 4.1. The
case with p ≤ 0.05 does not provide a good feature set: only 70% of the nodes are consistent,
and the high percentage of biomarker nodes would lead to a high-dimensional feature space.
The other two cases, p ≤ 0.01 and p ≤ 0.001, provide valid feature sets: they both present
high percentages of consistent nodes, and a sufficiently small number of biomarker nodes
(about 130 and 30 nodes respectively).
The areas which better discriminate Controls and AD can be visualized: in Fig. 4.5, each
location is color-coded with the median p-value evaluated over the Niter runs. From the
map, it is clear that the most discriminating areas of the ventricles are the left inferior medial
temporal horn, the right (superior and inferior) medial temporal horn, and the areas close to
the genu of the left side of the corpus callosum and the head of the right caudate nucleus.
Thus, we have detected two potentially good biomarker sets which can be used as features
during the training and testing of the SVM: the best biomarker set will lead to the best SVM
performances.
4.3.2 Biomarker’s Performances
As reported in Table 4.2, both scenarios (p ≤ 0.01 and p ≤ 0.001) present high performances
in terms of separability in the feature space (i.e. accuracy, 100% and 93% for p ≤ 0.01 and
p ≤ 0.001 respectively) and generalization (specificity 89% and 82%, sensitivity 86% and
86%, for p ≤ 0.01 and p ≤ 0.001 respectively); eventually, one is mostly interested in
detecting AD: the second test run on AD2 (sensitivity on unseen pathological cases) showed
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that the best performances are given by p ≤ 0.001, where a sensitivity of 76% is reached: the
corresponding areas are the inferior (left and right) medial temporal horns. A final note on the
results for the separability in the feature space: the good performances on this test strengthen
the hypothesis that permutation tests correctly highlight features on the ventricular surface
which strongly characterize the two groups.
4.4 Discussion
In this work, we have introduced a new framework to detect ventricular shape biomarkers for
AD, in clinical MR images. Shape modeling techniques, statistical nonparametric tests, and
support vector machines were merged together to prove the existence of such biomarkers and
to assess their performances. The idea of complementing shape analysis and pattern recog-
nition in one solution had already been explored in the literature: Golland et al. [18] showed
how, given two populations of shapes, it is possible to extract features, build a classifier-
function, and move back from the function to the shape differences in the image domain. In
our work, we proceeded in a different way: after having modeled all the ventricular shapes
with comparable meshes, repeated permutation tests were run to prove the consistency of
shape-based biomarkers differentiating ADs from healthy subjects. Once the consistency
had been proved, we assessed the biomarker’s performances, using them to build a classifier
which was trained to recognize Controls and ADs. Different sub-sets of features were tested,
and the most accurate one was selected as a biomarker set for AD.
One of the most common problems in pattern recognition is the curse of dimensional-
ity. When the feature space has a too high dimension compared to the number of available
samples, the training of the classifier becomes a very difficult task: the risk of over-fitting
increases and the generalization capabilities are potentially reduced. In our work, we had
a relatively small dataset (86 instances in total, 28 controls and 58 AD). Nevertheless, the
SVMs could provide good accuracies for all the experiments (leave-1-out experiment, and
sensitivity-test): as clearly explained in [17], SVMs are less subject to the curse of dimen-
sionality compared to other classifiers. Moreover, by setting the threshold on the p-values at
0.001, the feature space was fully described by only 30 nodes: under these conditions, our
Table 4.3: Performances of the Linear-SVM: results show the separability in the future space
(i.e. Accuracy, evaluated on Controls-AD1), the generalization capability (leave-1-out experi-
ment on Controls-AD1) reported as Success-Rate (Specificity/Sensitivity), and the sensitivity
on unseen pathological cases (AD2).
Separability in the Generalization Sensitivity
Feature Space (Specificity/Sensitivity) (unseen dataset)
p ≤ 0.01 96% 86% (82% / 90%) 66%
p ≤ 0.001 93% 84% (82% / 86%) 76%
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dataset was sufficiently large to train the classifier.
The results of our analysis were very promising, and allowed us to some further consid-
erations. The repeated permutation tests showed a pattern of shape-based features which was
consistent regardless of the chosen training set. This strongly supports the idea that stable
biomarkers for AD can be found in the shape of the brain ventricles: particularly important
areas are the left inferior medial temporal horn, the right inferior and superior medial tempo-
ral horn, and the areas close to the left anterior part of the corpus callosum and the head of
the right caudate nucleus.
The second important contribution of our work was the assessment of features’ reliability,
by means of a SVM. Different sub-sets of the pattern highlighted by the permutation tests
were analyzed to determine the most accurate biomarker set. Both for p ≤ 0.01 and p ≤
0.001, the analysis showed a common trend: the leave-1-out experiments gave excellent
results (88% and 84% successful rate), and the sensitivity on unseen AD cases resulted in
66% and 76% for p ≤ 0.01 and p ≤ 0.001 respectively. Despite the limited number of
datasets in the populations, shape-based biomarkers could successfully discriminate healthy
subjects and ADs, particularly when the inferior (left and right) medial temporal horns were
used (p ≤ 0.001).
4.4.1 Comparison with other methods
When comparing our results with alternative methods, there are two aspects to consider:
which biomarkers we have found, and what is the diagnostic accuracy of such biomarkers.
The shape-based biomarkers identified by our method can be grouped in four main areas:
(1) the left inferior medial temporal horn, (2) the right inferior and superior medial temporal
horn, (3) the area close to the left anterior part of the corpus callosum, and (4) the head
of the right caudate nucleus. These results are in agreement with the recent publications
on AD progression. In [19], Kodama et al. showed that the hippocampal area index was
significantly different between controls and AD (the same was true for the ventricular area
index). In Wang et al. [20], it was shown that different patterns of hippocampal shape change,
and different rate of hippocampal volume loss can distinguish mild AD from healthy subjects.
In [21], Barnes et al. investigated subjects with AD and Frontotemporal Lobe Degeneration
(FTLD): they showed that volume loss rate of both hippocampus and cingulate gyrus are
useful to discriminate between healthy subjects and AD, and healthy subjects and FTLD.
Similar conclusions about the hippocampus were drawn in [22] and [23], where the authors
also reported an important role for the (left) amygdala volume loss rate in differentiating
between healthy subjects, AD, and FTLD. Finally, Thompson et al. [24] have investigated
cortical changes in longitudinal studies, showing that cortical deficits on the right hemisphere
spread from the temporal-parietal and entorhinal areas to the cingulate gyrus (while a more
global cortical loss is reported on the left side). Our method, indirectly, pinpointed to the
same regions: the left inferior medial temporal horn reflects atrophy in the left hippocampus
and left amygdala; the right medial temporal horn reflects atrophy in the right hippocampus;
finally, the areas close to the left genu of the corpus callosum and head of caudate nuclei
might reflect atrophy in the cingulate gyrus. The advantage of our method is that it is based
on ventricular CSF: thanks to the good image contrast, the ventricle segmentation can be
73
CHAPTER 4
accurately performed semi-automatically even in clinical MR images (as reported in this
study), and is more reliable and less time-consuming than the delineation of small gray/white
matter structures. Moreover, the analysis of one single structure (the brain ventricles) directly
highlights local atrophy in all the periventricular structures.
The second important aspect to consider is the accuracy with which our biomarkers differ-
entiate healthy subjects from AD. In most of the papers previously cited, the authors reported
the sensitivity (accuracy in detecting AD) and specificity (accuracy in detecting healthy sub-
jects) associated with their biomarkers. Kodama et al. [19] reported a sensitivity/specificity of
90.2%/81.8% (overall accuracy of 87.7%) for their combined Volume - Area - Index and Hip-
pocampus - Area - Index; although the results look very promising, the discriminant analysis,
based on Mahalanobis distance from the mean values, was performed on the same dataset
(51 AD and 22 controls) used to obtain the mean values and the standard deviations. In [20],
Wang et al. reported a sensitivity of 83.3% and a specificity of 84.6% (overall accuracy of
about 84%) for their longitudinal study based on 18 AD and 26 controls: in this case, the
results were based on a leave-1-out experiment. Finally, Barnes et al. reported a specificity
of 80% and sensitivities of 65% for atrophy rate of right amygdala volume, 80% for atro-
phy rate of left amygdala volume, 90% for atrophy rate of left and right cingulate gyrus, and
about 93% for atrophy rate of left and right hippocampus [21, 23]; these values were obtained
by using regression models on datasets of 10 AD and 11 controls. The accuracies obtained
with our method are certainly in line with the previously reported results, and present some
advantages. Considering the cases p < 0.01 and p < 0.001, the accuracy for the leave-1-out
experiment (Contr. vs AD1) is about 86% (in average), slightly better than the overall accu-
racy reported by Wang et al. [20] (the only study in which we found a clear reference to the
leave-1-out test). One of the main contributions of our work is that the sensitivity of 76% was
evaluated on a previously unseen dataset of ADs, in contrast to what reported in all the other
studies.
In conclusion, our results suggest that biomarkers for AD can be detected in clinical MR
images: although our datasets are larger than those reported recently in the literature, future
work should aim at larger populations to improve the detection of the biomarkers and to build
stronger machines for the detection of AD. Moreover, different biomarker sets and classifiers
might be investigated for different pathological groups, like MCI converters versus MCI non
converters: such a machine would be extremely helpful in clinical routine to decide which
patients should be treated for AD.
4.5 Appendix
The SVM presented in this work is a non-linear classifier based on RBFs. A non-linear
classifier is more prone to over-fitting, especially when trained on a relatively small dataset.
Linear classifiers, on the other hand, are less prone to over-fitting, but might provide worse
performances.
Thus, we implemented a SVM linear classifier and evaluated its performances. Results
are shown in Table 4.3. As expected, the separability in the feature space gets slightly worse.
The generalization capability is the same for p ≤ 0.001, and gets slightly worse for p ≤ 0.01
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Table 4.4: Performances of the RBFs- and Linear-SVM with feature selection based on
Controls-AD1 and testing based on Controls-AD2.
RBF Linear
Separability in the Generalization Separability in the Generalization
Feature Space (Spec./Sens.) Feature Space (Spec./Sens.)
p ≤ 0.01 100% 79% (82%/76%) 86% 77% (79%/76%)
p ≤ 0.001 100% 79% (71%/86%) 95% 79% (75%/83%)
(from 88% to 86%, with sensitivity of the leave-1-out increasing from 86% to 90%); finally,
the sensitivity on the unseen dataset does not change. The results are comparable, suggesting
that the SVM based on RBFs does not suffer for over-fitting.
4.5.1 Tuning of the SVM
Two parameters need to be tuned for a SVM based on RBFs: the constant C > 0, and
the γ parameter of the kernel function. The procedure and values used for tuning are the
same as suggested by Hsu et al.: A Practical Guide to Support Vector Classification (cite-
seer.ist.psu.edu/689242.html).
Given a training set Tr Set, a grid search is performed over the C x γ space:
1. ∀ (C,γ) ∈ [2−5, 2−3, 2−1, .., 215]x[2−15, 2−13, 2−11, .., 23]
(a) assess the generalization capability of the SVM(C,γ) with leave-1-out over Tr Set;
(b) store the success rate for (C, γ): succRate(C,γ);
2. Select the best (C, γ) = argmax(C,γ) (succRate(C,γ));
3. Perform a refined grid search (as in point 1) in the surrounding of (C, γ): e.g., if
C = 2−3 and γ = 2−13, search within [2−5, 2−1]x[2−15, 2−11] with steps equal to one
tenth of the intervals;
4. Select the final best (C, γ);
5. Train the SVM(C, γ) on the entire training set.
In case of a linear SVM, only C needs to be tuned. The results for the RBFs SVM are
(C, γ) = (2, 0.3125) and (C, γ) = (128, 4.8828 ∗ 10−4) for p ≤ 0.01 and p ≤ 0.001
respectively.
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4.5.2 Training and Testing
While training and testing a classifier, results should not be biased, nor based on too small
datasets. Ideally, one would want to perform feature selection and tuning/training on one
training set, and validate the results on an independent testing set. Both training set and
testing set should contain enough objects per category, to make sure the classifier does not
over-fit on one class. When not enough data is available, leave-1-out tests can be used.
In our work, we had 28 controls and 58 ADs. Because of the limited number of controls,
we had to compromise on the experiments, still trying to maintain unbiased results. Priority
was given to the sensitivity test on the dataset of unseen AD. Therefore, we first split the AD
group in two (AD1 and AD2), and kept the AD2 for testing. Since we have shown in this
work that biomarker sets are rather independent by the sub-sampled AD group, we are quite
confident that feature selection on Controls-AD1 does not bias the results of the validation
test on Controls-AD1. Moreover, this gives us the opportunity of testing the sensitivity on an
entire dataset of unseen objects (AD2).
A different choice could have been made: selecting the features on Controls-AD1, and
validate the SVM on Controls-AD2 (removing the bias for the AD subjects). Nevertheless,
the sensitivity could then be tested only with leave-1-out tests on Controls-AD2. We per-
formed these experiments for both the RBFs- and linear-SVM. Results are shown in Table
4.4. The results are quite similar to those obtained with the original framework, showing
that selecting features on Controls-AD1 and testing on Controls-AD1 does not lead to biased
results.
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CHAPTER 5
Variation in Ventricular Shape between Cognitively
Normal, Memory Complainers, Mild Cognitive Impairment
and Alzheimer’s Disease
Of all the things I have lost, I miss my mind the most.
Mark Twain, 1835-1910.
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Abstract Our objective was to assess whether differences in cerebral ventricular shape exist
between groups of cognitively healthy subjects, individuals with subjective memory com-
plaints (MC), patients with mild cognitive impairment (MCI) and patients with probable
Alzheimer’s Disease (AD). We included 28 healthy subjects, 21 MC subjects, 28 MCI pa-
tients, and 63 probable AD patients from our outpatient memory clinic. FLAIR, T2 and
PD-weighted brain MRI scans were acquired at 1.5 T. Volumetric assessment was performed
through semi-automated segmentation of the lateral and third ventricles, followed by statisti-
cal shape modeling based on GAMEs (Growing and Adaptive MEshes). We generated mesh
models for all the ventricle shapes and used them to highlight local areas with significant
differences between the healthy subjects and the remaining groups: permutation tests with a
predefined threshold (p = 0.01) were used for the statistical analysis. Results were analyzed
both within a group, to highlight asymmetric behaviour in left and right structures due to a
pathological condition, and between groups to highlight trends in ventricular shape changes
across the clinical spectrum of cognitive impairment: MC and MCI presented significantly
different areas mainly on the right side of the ventricular system, AD mainly on the left side.
The analysis across the spectrum showed that some ventricular areas mostly characterize AD
(left side of the corona radiata, right inferior medial temporal horn, etc.), others MCI (right
side of the thalamus, right side of the corona radiata, right caudate nuclei), and others present
a clear trend through the spectrum.
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5.1 Introduction
Magnetic Resonance Imaging (MRI) has been a valuable tool for the detection of structural
brain changes in subjects with Mild Cognitive Impairment (MCI) and Alzheimer’s Disease
(AD) [1–3]. Many authors have studied atrophy by segmenting brain parenchyma into gray
matter (GM) and white matter (WM), using measurements such as the total gray matter vol-
ume [2, 4], hippocampal volume [1, 5, 6], and cortical thickness [3]: all these methods depend
on the distinction between cerebral gray matter and white matter in MRI. The decline of con-
trast between white matter and gray matter is inherent in aging, and has a histological basis
that can not be resolved with MRI. Thus, the age-associated decline of contrast may lead to
skewed conclusions as a result of the image processing.
A different approach to detect and quantify atrophy is to measure the volume of the in-
tracranial CSF compartments: the loss of parenchyma leads to a compensatory dilation of the
CSF within the fixed intracranial volume. The contrast between CSF and brain parenchyma
is much more pronounced than the contrast between GM and WM, and does not decrease
significantly with aging: therefore, this method is not likely to suffer from the same pitfalls
as GM and WM segmentation.
The quantification of CSF volumes to study atrophy has previously been applied to MCI
and AD research; many studies used the ventricle-to-brain ratio, a measure reflecting global
parenchyma loss [1, 7]. Others described the CSF volume of a specific part of the ventricular
system, such as the temporal horns, reflecting hippocampal atrophy [8, 9]. The use of the total
volume of the ventricular system to determine the amount of atrophy is a simple, but coarse
approach, since atrophy of different parts of the brain are blended into a single measurement:
cognitive impairment associated with atrophy may involve multiple brain areas, which can
not be distinguished using one global measurement of atrophy.
Our aim is to visualize and quantify localized cerebral ventricle shape differences between
cognitively healthy subjects, subjects with memory complaints in the absence of cognitive
impairment (memory complainers, MC), MCI patients and probable AD patients. For this
purpose, we used automatic shape modeling to generate mesh models of all the ventricle
shapes, and used them to highlight local areas with significant differences between the four
groups of subjects.
The automatic shape modelling technique has previously been applied to the study of
cognitively healthy and AD [10]. In the present study, we expand on these results with an
increased number of subjects and the addition of both MC and MCI patients, in an attempt to
study a more detailed spectrum from cognitively healthy to AD.
5.2 Materials and Methods
5.2.1 Subjects
Elderly subjects that were consecutively referred to our outpatient memory clinic partici-
pated in this study. We included 63 patients with probable AD, 28 patients with MCI, 21 pa-
tients who were evaluated for memory complaints (MC patients) but who had no detectable
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Figure 5.1: Mesh model of a brain ventricle, projected on a PD MRI image.
cognitive deficits on neuropsychological testing, and 28 volunteers without memory com-
plaints who were recruited through an advertisement in a local newspaper. All subjects were
evaluated using a standardized dementia screening analysis that included a detailed medi-
cal history, a general internal and neurological exam, laboratory tests, neuropsychological
testing (including the Mini Mental State Examination (MMSE)) and MRI of the brain. Diag-
noses were made in a multidisciplinary consensus meeting, according to the National Institute
of Neurological and Communicative Disorders and Stroke-Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA) criteria for probable AD, and the Petersen cri-
teria for MCI: (1) memory complaint; (2) impaired memory function on cognitive testing;
(3) preserved general cognitive functioning; (4) intact activities of daily living; (5) not de-
mented. Patients and controls were included if they: (1) were older than 60 years; (2) had
no other neurological or psychiatric illness; and (3) had no abnormalities on MRI other than
white matter hyperintensities or an incidental small lacunar lesion (≤ 5mm diameter). The
study was approved by the local Medical Ethical Committee. Written informed consent was
obtained from all subjects or from a close relative if a patient was demented.
5.2.2 MR image acquisition and pre-processing
MRI was performed on a 1.5 T MR system (Philips Medical Systems, Best, The Netherlands).
Conventional dual fast spin-echo sequences [48 axial slices; slice thickness = 3mm; no gap;
TR/TE (ms) 3000/27/120; flip angle = 90 ◦; field of view = 220 mm; matrix 256x256] were
obtained for all patients. The line through the inferior border of the genu and splenium of the
corpus callosum defined the direction of scanning. Using in-house developed software, we
automatically extracted the intra-cranial cavity, the CSF, and white matter hyperintensities:
semi-automatic region growing was used to re-label the ventricular CSF as brain ventricles.
All the images were then corrected for brain-size and orientation using automatic affine 12-
parameters registration to the LUMC T2-weighted brain template for geriatrics [11–13].
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Figure 5.2: Clustering of nodes in areas corresponding coarsely to the corona radiata (light
brown), corpus callosum (green), caudate nucleus (light blue), thalamus (brown), upper me-
dial temporal horn (red) and inferior medial temporal horn (yellow).
5.2.3 Ventricular shape modeling
Local shape analysis requires, as a first step, the modeling of the brain ventricles with com-
parable meshes: following a previously introduced procedure for automatic shape modeling
technique [14], healthy subjects were used to generate an average brain ventricle volume,
whose surface was modeled by a growing and adapting mesh; subsequently, the topology of
the mesh (i.e. nodes and edges) was frozen and its shape was adapted to all the ventricles in
the study (see Fig. 5.1). This resulted in a set of comparable meshes: each node in a given
mesh is uniquely associated with corresponding nodes in other meshes.
5.2.4 Ventricular surface parcellation
In order to quantify the extent of local shape differences in the different groups and relate it
to particular periventricular structures, we manually parcellated the total ventricular surface
into regions, according to the adjacent anatomical structures: the left and right corona radiata,
the left and right side of the corpus callosum, the left and right caudate nuclei, the left and
right thalamus, the left and right upper medial temporal horns and the left and right inferior
medial temporal horns. This manual delineation was performed only once, using a regular
anatomical atlas, on the template used to normalize all the brain images [15]. The mesh’s
nodes were associated with the closest overlapping region, and clustered together in corre-
sponding surface areas (see Fig. 5.2). The purpose of our manual delineation was to generate
a meaningful regional parcellation of the ventricular surface, rather than to obtain an accurate
delineation of the corresponding periventricular structures: such a parcellation allows a more
detailed quantitative analysis of the differences between the groups.
5.2.5 Statistical shape comparison
Given two populations of brain ventricle meshes, permutation tests1 were applied at each
node location to evaluate the significance of local shape differences: each location (i.e. node
in the mesh) of the ventricles was associated with a p value, rendered with a color code on the
1Permutation tests [16] are sound non-parametric statistical tests: they require minimum hypothesis (i.e. same
kind of distribution for the populations) and correct for multiple comparisons.
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Figure 5.3: Local differences in ventricular shape between cognitively healthy and mem-
ory complainers, subjects with MCI and subjects with AD. Local shape differences between
groups are represented by color-coded p-values (p values > 0.01 are color-coded in blue).
The corresponding colored Figure can be found at page 16, before Chapter 2
ventricular surface, as shown in Fig. 5.3. Locations with a p value below 0.01 were chosen as
characteristic features for the brain ventricle’s shapes. Displacement vectors were also evalu-
ated at each location found to be significantly different: considering two groups, i.e. healthy
subjects and ADs, one could generate two average meshes and evaluate the displacement
in space between corresponding nodes. Visual inspection of displacement vectors between
cognitively healthy and the remaining groups showed that changes occurred as a result of
enlargement of the ventricles in the group with the lower cognitive status. This is illustrated
in Fig. 5.4, for the case of cognitively healthy vs. AD patients. Ventricular shape differences
between populations were expressed in extent of change, reflecting the extent of local atrophy
and represented by the percentage of nodes significantly different in each area, and severity
of change, reflecting the severity of atrophy and represented by the average displacement per
area.
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Figure 5.4: The direction of the displacement vectors in these images demonstrates that
changes between an average cognitively healthy subject and an average AD occur as a re-
sult of ventricular enlargement. The corresponding colored Figure can be found at page 16,
before Chapter 2.
5.3 Results
Statistical shape modeling and analysis resulted in the assessment and visualization of local-
ized ventricular changes along the clinical cognitive spectrum. These changes reflect atrophy
in adjacent periventricular gray and white matter structures, whose extent and severity are de-
scribed in Table 5.1. While analyzing these results, it is important to account for small image
registration errors: therefore, changes in extent of atrophy among group comparisons (i.e.
from controls to MCI and to AD) are considered relevant only if they differ for at least 5%,
while changes in severity of atrophy are considered relevant when around 1 mm or higher.
The results reported in Table 5.1 lead to two different kinds of analysis. Focusing on a
given structure, e.g. the corona radiata, and on a given column (e.g. Controls vs. AD), one
can assess the asymmetry between left and right sides due to the particular condition (e.g.
AD), both for the extent and the severity of atrophy: asymmetries in the extent of atrophy
(e.g., left/right inferior medial temporal horns in AD) were considered relevant when (1) the
extents differ for more than 5% (e.g., 27% in the right and 47% in the left), and (2) involved
more than 5% of the nodes (27% and 47% > 5%); asymmetries in the severity of atrophy
were considered relevant when (1) the severities differ for more than 1 mm and (2) involved
more than 5% of the nodes. When focusing on a row (e.g., left corona radiata), on the other
hand, one can highlight trends across the cognitive spectrum.
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Table 5.1: Six periventricular areas were chosen to study localized ventricular shape differ-
ences. The left and right hemispheres were studied separately. Percentage of significantly
different nodes (in %, per area) and average displacement (in mm, per area) reflect the extent
and severity of atrophy respectively.
Total Number Controls vs.
of Nodes MC MCI AD
%/mm %/mm %/mm
Corona Radiata R 88 0 0 1 +3.4 0 0L 91 0 0 2 +2.7 11 +2.8
Corpus Callosum R 140 5 +1.8 5 +2.6 1 +1.7L 153 2 +0.7 1 +2.6 1 +3.6
Caudate Nuclei R 32 0 0 41 +2.2 6 +2.5L 30 0 0 17 +2.6 27 +2.9
Thalamus R 50 2 +0.9 16 +1.4 8 +2.1L 38 3 +0.4 0 0 3 +2.6
Sup. Med. Temp. Horn R 99 2 +1.3 1 +3.2 30 +2.8L 122 0 0 3 +1.2 11 +2.1
Inf. Med. Temp. Horn R 55 13 +1.1 15 +2.0 27 +2.9L 51 2 +1.3 49 +2.5 47 +3.1
5.3.1 Left and right asymmetry
The results for left and right asymmetry are highlighted in Table 5.2: for each structure and
for each group comparison, the table reports relevant asymmetrical behaviour, both for the
extent and the severity of atrophy. The same insight can be achieved visually, comparing the
statistical maps in Fig. 5.3. Memory complainers present a higher extent of atrophy in the
right inferior medial temporal horn. Patients with MCI present more severe atrophy in the
right side of the thalamus, as well as a higher extent to atrophy in the right caudate nucleus,
right side of the thalamus, and left inferior medial temporal horn. Finally, subjects with AD
present more severe atrophy in the left corona radiata, as well as a higher extent of atrophy in
the left corona radiata, left caudate nucleus, left inferior medial temporal horn, right side of
the thalamus, and right superior medial temporal horn. In general, it is notable that MC and
MCI are mostly affected on the right side of well-defined structures, while ADs are apparently
more affected on the left side.
5.3.2 Trends across the cognitive spectrum
Corona Radiata - The left side of the corona radiata presents a relevant change in extent of
atrophy in AD, as well as a relevant severity of atrophy both in MCI and AD. The right side,
on the other hand, does not show any relevant change in the extent of atrophy: it is instead
notable that MCIs present a relevant severity of atrophy when compared to both MC and AD.
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Table 5.2: Six periventricular areas were chosen to investigate asymmetry of localized ven-
tricular shape differences across the cognitive spectrum. Considering the results in Table 5.1,
this table shows, for each structure, whether a relevant asymmetry is present or not (both in
terms of extent and severity of atrophy). An R(L) indicates that the right (left) side is more
affected.
MC MCI AD
Ext./Sev. Ext./Sev. Ext./Sev.
Corona Radiata - - - - L L
Corpus Callosum - - - - - -
Caudate Nuclei - - R - L -
Thalamus - - R R R -
Sup. Med. Temp. Horn - - - - R -
Inf. Med. Temp. Horn R - L - L -
Corpus Callosum - The extent of atrophy does not change relevantly across the cognitive
spectrum, neither on the left nor on the right side. The severity of atrophy, on the other hand,
presents a relevant trend on the left side, increasing while moving from MC to AD.
Caudate Nuclei - The right caudate nucleus presents a relevant change in extent of atrophy
both in MCI and in AD, when compared to MC; even more striking is the much higher extent
in MCI, compared to both MC and AD. Concerning the severity of atrophy, relevant changes
are highlighted both in MCI and AD, compared to MC, while no relevant difference is found
between MCI and AD. The same severity patter is present in the left caudate nucleus, while
the extent of atrophy presents a clear trend through the cognitive spectrum.
Thalamus - Concerning the extent of atrophy, the right side of the thalamus presents the same
behaviour previously observed for the right caudate nucleus: MCIs show a relevant change
when compared to both MC and AD, although even ADs present a higher extent of atrophy
than MC. The change in severity of atrophy, both in the right and left sides of thalamus, is
relevant only in AD.
Superior medial temporal horn - The extent of atrophy presents a relevant change in AD,
when compared to MC and MCI, both in the left and right horns. Changes in the severity of
atrophy are relevant both in MCI and AD (both in the right and left horns), when compared
to MC, while no relevant difference appears between MCI and AD.
Inferior medial temporal horn - The right inferior medial temporal horn presents a relevant
change in extent of atrophy in AD, while the left inferior medial temporal horn presents
relevant changes both in MCI and AD. The severity of atrophy follows a similar pattern: in
the right inferior horn, only AD shows a relevant change, while in the left one both MCI and
AD presents relevant changes when compared to MC.
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5.4 Discussion
In this study, we have investigated local ventricular shape differences among different groups,
across the spectrum of cognitive function: healthy subjects where compared to memory
complainers, mild cognitive impairments, and subjects with Alzheimer Disease. The cross-
sectional analysis of group comparisons (e.g. Controls vs. AD) highlighted relevant asym-
metrical shape differences between left and right structures due to the particular pathology,
while the analysis across the cognitive spectrum highlighted particular trends in the extent
and severity of atrophy.
The most striking findings, concerning left and right asymmetry, were predominantly
worse conditions (both in terms of extent and severity of atrophy) on the right side of well-
defined structures (such as caudate nucleus and thalamus) in MC and MCI. Subjects with
AD, on the other hand, presented worse conditions mostly on the left side of periventricular
structures: corona radiata, caudate nucleus, and inferior medial temporal horn. In AD, a pre-
dominant involvement of the right side was shown only in the thalamus and superior medial
temporal horn.
The interpretation of our results across the cognitive spectrum leads to further considera-
tions. The left caudate nucleus and the left side of the corpus callosum presented a relevant
trend while moving from MC to AD: the former presented increasing extent of atrophy, while
the latter presented increasing severity of atrophy. The left inferior medial temporal horn pre-
sented a relevant change in both extent and severity of atrophy while moving from MC to
MCI/AD: the same pattern was found for the severity of atrophy in the caudate nuclei (left
and right), and the superior medial temporal horns (left and right). Alzheimer Disease dif-
fered from both MC and MCI for the extent of atrophy in the right and left superior medial
temporal horns, and right inferior medial temporal horn; similar patterns were found for the
severity of atrophy in the thalamus and the right inferior medial temporal horn. Finally, well
specific regions seemed to characterize MCI: relevant changes when compared to both MC
and AD were found for the extent of atrophy in the right caudate nucleus and right thala-
mus, and for the severity of atrophy in the right corona radiata and right side of the corpus
callosum.
Few publications describe a direct relationship between damage to the corona radiata and
cognitive decline. Subtle cognitive impairment and emotional disturbances were found in pa-
tients with a single lacunar infarct in the corona radiata [17]. Similar findings are described
in a number of reports on lacunar infarcts in supratentorial structures [18–20]. In the litera-
ture, no consistent pattern was found between the involved supratentorial structures and the
neuropsychological impairments. To the best of our knowledge, the corona radiata has never
been previously described as a possible biomarker for the detection and follow up of neu-
rodegenerative diseases involving memory loss. Our results indicate that local changes in the
surface of this structure may differentiate between cognitively healthy subjects and subjects
with AD and MCI.
The caudate nucleus forms part of a cholinergic network, consisting of central cholinergic
neurons, which are thought to be involved in a number of neurodegenerative diseases, includ-
ing AD [21]. Disturbance of the central cholinergic system does not appear to be closely
related to the etiology, but to the development of clinical symptoms [21]. A relationship be-
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tween caudate nucleus volume and a number of dementing illnesses such as AD, Dementia
with Lewy Bodies and Vascular Dementia has been described before [22]. Volumetric analy-
sis of the caudate nucleus on MRI was not found to discriminate between diagnostic groups.
However, our results indicate that changes in the ventricular area adjacent to the caudate nu-
cleus occur between cognitively healthy subjects, subjects with MCI and AD, which may
point to the caudate nucleus as a biomarker for MCI and AD.
The role of the thalamus in the development of cognitive decline in AD may be of vas-
cular origin, superimposed on AD pathology [23]. Subcortical small lesions involving the
thalamus disrupt cortico-subcortical circuits, resulting in cognitive dysfunction. Our results
show that the extent of atrophy in the right side of the thalamus might be a good indication
for MCI, while the severity of atrophy on the left side seems to be characteristic of AD. It is
widely accepted that structural changes of the medial temporal lobe, where the amygdala and
hippocampus are located, are associated with an increased risk of MCI and AD [1, 8, 24, 25].
Though our association between medial temporal lobe atrophy, MCI and AD is not new, it
emphasizes the ability of our technique to detect clinically relevant changes to periventricular
gray matter structures.
Finally, significant cerebral shape differences were found between cognitively healthy
subjects and subjects with subjective memory complaints. Although the latter group of sub-
jects has non-objectifiable memory impairment, our results indicate that anatomically these
subjects may be classified in a distinct group. These results are in accordance with those from
numerous other studies [26, 27].
The strengths of the present study include the clear classification of subjects into four
cognitive groups through an extensive neuropsychological test battery, as well as the use of a
validated automated set-up of our statistical shape modeling method. To our knowledge, this
is the first study that not only describes the association of structural changes of the surface of
the medial temporal lobe with cognitive decline in MCI and AD, but also includes the entire
surface of the ventricular system, in search of potential biomarkers of neurodegenerative
disease involving memory loss (MC, MCI, and AD). The results might be strengthened in the
future by means of larger datasets; moreover, a further distinction between MCI converters2
and non-converters might lead to more consistent patterns across the spectrum of cognitive
function.
5.5 Conclusions
In this work, we have shown that localized changes in ventricular shape may differentiate
between cognitively healthy subjects, subjects with subjective memory complaints, subjects
with MCI and subjects with AD. The corona radiata, caudate nucleus and thalamus are added
to the well-established medial temporal lobe as possible structural biomarkers of cognitive
decline.
2With MCI-converters we refer to MCI patients who eventually convert to an AD type of dementia.
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CHAPTER 6
MMSE Scores Correlate with Local Ventricular
Enlargement in the Spectrum from Cognitively Normal to
Alzheimer Disease
All change is not growth, as all movement is not forward.
Ellen Glasgow, 1873-1945.
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Abstract In this work, we aimed at correlating focal atrophy in periventricular structures with
cognitive function, in the spectrum from healthy subjects to severe Alzheimer Disease: 28
subjects with normal cognition and 84 patients presenting various degrees of cognitive im-
pairment were included in the study. The cognitive level of each subject was assessed with the
Mini Mental State Examination (MMSE). Atrophy in periventricular structures was inferred
by modeling and analyzing local shape variations of brain ventricles: for a given subject, we
distinguished between the severity of atrophy, estimated as local enlargement (in mm) of the
ventricular surface relative to an average normal subject, and the extent of atrophy, defined
as the percentage of the ventricular surface (global or per anatomical region) significantly
different from an average control. Linear regression across subjects was performed to evalu-
ate the correlation between atrophy and MMSE score. The severity of atrophy showed good
correlation with MMSE score in the left thalamus, the left temporal horn, the left corona ra-
diata, and the right caudate nuclei. The extent of atrophy showed no significant correlations.
In conclusion, the MMSE scores correlate with localized depth of atrophy in well-defined
periventricular structures.
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6.1 Introduction
Dementia is usually defined as a progressive decline of cognitive function. Among the sev-
eral possible causes of dementia, Alzheimer Disease (AD) is usually regarded as the most
common one. Considering the spectrum of cognitive function, healthy subjects are at one
side, presenting normal cognitive level, while patients with severe Alzheimer Disease (AD)
are at the very opposite end. An important intermediate position is represented by the Mild
Cognitive Impairment (MCI): patients suffering of MCI experience isolated memory deficits
(amnesia), but are otherwise cognitively capable and not limited in their daily life. Growing
evidence of how AD affects brain structures has previously been presented: hippocampal
atrophy [1–5]; rapid degeneration of prefrontal lobe [6, 7]; atrophy of entorhinal cortex [8–
11]; pronounced atrophy of the corpus callosum [12–14]. Similar studies have analyzed the
effects of MCI and its relationship with AD [15–17].
Several cognitive tests exist to assess the cognitive level of an individual. One of them,
the Mini Mental State Examination (MMSE) [18], has largely been used in clinical practice
for the diagnostic work up of AD and MCI. Conspicuous attempts to correlate MMSE scores
with brain structural changes, as captured by Magnetic Resonance Imaging (MRI), have re-
cently been reported in the literature: in [19], a high correlation in AD between MMSE scores
and changes in temporal horns was reported; in [20], a high correlation between cognitive
impairment and selective white matter damage in AD, measured as a reduction of fractional
anisotropy, was shown (particularly in the splenium of the corpus callosum); in [15], the cor-
relation between MMSE scores and hippocampal volume changes was investigated, finding
no significant correlation in MCI-converters1; in [21], the authors showed high correlation in
AD between MMSE scores and decrease of gray matter in the left temporal lobe; finally, a
strong correlation between MMSE scores and gray matter loss in several cortical regions was
observed in clinical and pre-clinical AD [22].
The aim of our study was to investigate to what extent the MMSE score correlates with
atrophy in periventricular structures. Any change in volume or shape in these structures must
be reflected on the shape and volume of the brain ventricles: thus, by analyzing shape vari-
ations in the entire ventricular system we could indirectly estimate the degree of atrophy in
all the periventricular structures. The delineation of small gray and white matter structures is
a challenging task, particularly in elderly subjects, due to the loss of contrast between differ-
ent tissues [23]: (semi-) automatic segmentation is error prone and not always reproducible,
while manual delineation is highly time consuming. Cerebrospinal fluid (CSF), on the other
hand, can be automatically and reliably segmented, thanks to its sharp contrast with respect to
the rest of the parenchyma. While analyzing atrophy, we introduced a distinction between the
severity of atrophy and the extent of atrophy. The former was estimated as local enlargement
(in mm) of the ventricular surface with respect to a normal average case; the latter was given
by the percentage of ventricular surface significantly different from an average normal case.
Finally, rather than focusing on only one specific pathological condition, such as AD or MCI,
we included subjects from both groups, covering a larger area in the spectrum of cognitive
impairment.
1Among the subjects affected by MCI, some convert in time into AD and are referred to as MCI-converters.
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Table 6.1: Demographic Data: Total number of subjects per group (and total number of male),
Age (in years), and MMSE score.
Controls Patients
Tot (N. Male) 28 (12) 84 (38)
Age µ(σ) 74 (6.9) 74 (7.3)
MMSE µ(σ) 27.6 (1.7) 20.8 (5.6)[min-max] [24-30] [4-30]
6.2 Material and Methods
6.2.1 Subjects
The subjects included in the study were chosen so that a larger area in the spectrum of cog-
nitive function could be represented: 28 volunteers with normal cognitive function, and 84
patients presenting different degrees of cognitive impairment (26 subjects with MCI and 58
patients affected by AD, ranging from mild to severe cases). The volunteers were recruited
through advertisements in local newspapers, while patients with cognitive impairment were
consecutively referred to our outpatient memory clinic. The cognitive status was evaluated
for all subjects using a standardized dementia screening, including a detailed medical his-
tory, a general internal and neurological exam, laboratory tests, neuropsychological testing
(i.e., MMSE), and magnetic resonance images of the brain. Diagnoses were made in a mul-
tidisciplinary consensus meeting, according to the National Institute of Neurological and
Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders Associa-
tion (NINCDS-ADRDA) criteria for probable AD, and the Petersen criteria for MCI. Table
6.1 shows the demographic data: t tests performed on age and sex showed no significant
difference between groups (p ≤ 0.01). Subjects were included if they were older than 60
years, had no other neurologic or psychiatric illness, and had no abnormalities on MRI other
than white matter hyperintensities or an incidental small lacunar lesion (≤ 5 mm diameter).
Approval by the local Medical Ethical Committee was granted to the study. Written informed
consent was obtained from all subjects or from a close relative if a patient was demented.
6.2.2 MRI acquisition and Image pre-processing
Magnetic resonance images were acquired on a 1.5-T MR-system (Philips Medical Systems,
Best, The Netherlands) using the following pulse sequences: dual fast spin-echo (proton
density and T2 weighted): time to echo (TE) 27/120 ms, repetition time (TR) 3000 ms, 48
contiguous 3-mm slices without an interslice gap, matrix 256 x 256, field of view (FOV)
220 mm. FLAIR (fluid attenuated inversion recovery): TE 100 ms, TR 8000, 48 contiguous
3-mm slices without an interslice gap, matrix 256 x 256, FOV 220 mm.
Images were pre-processed with our in-house developed automatic-segmentation soft-
ware [24], which automatically extracted the intracranial cavity, the CSF, and the white mat-
ter hyperintensities. Three-dimensional region growing was applied to re-label the ventricu-
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Figure 6.1: (Top) Shape modeling of an average ventricle: a mesh grows and adapts to model
an average control surface. (Bottom) The ventricle volume was manually divided in regions,
according to the adjacent periventricular structures, and each node was labeled accordingly.
lar CSF as ventricles. Automatic affine 12-parameters image registration [25] was applied to
normalize all the images and the ventricular segmentations to the LUMC T2-weighted brain
template for geriatrics [26], in order to correct for brain-size and orientation.
6.2.3 Shape Modeling
The measure of focal atrophy in periventricular structures is based on the corresponding de-
formations occurring in the shape of the brain ventricles. Thus, as a first step one needs to
model all the brain ventricles with comparable meshes. This was done with an automatic
modeling technique previously introduced in [27]: the healthy subjects are used to generate
an average brain ventricle image, whose surface is modeled by a growing and adapting mesh
(see Fig. 6.1 (top)); subsequently, the mesh’s structure is frozen (nodes are not added nor
removed), and the mesh’s shape is automatically adapted to all the ventricles in the study,
ending up with comparable meshes (i.e. each node in a given mesh is uniquely associated
with corresponding nodes in the other meshes). Local changes in ventricular shapes should be
associated with focal atrophy in periventricular structures: thus, an expert was asked to manu-
ally delineate several regions on the initial average ventricular volume, each corresponding to
an adjacent periventricular structure. Nodes in the first mesh were then labeled accordingly to
the closest region (see Fig. 6.1 (bottom)), and labels were propagated to all the other meshes.
We visually inspected the results across all the meshes, to guarantee correct correspondence
between labels and adjacent periventricular structures. In the remaining of this paper, the
terms region left (right) corona radiata, region left (right) caudate nuclei, etc., will refer to
the sets of nodes associated with the corresponding periventricular structures.
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Figure 6.2: Extent of Atrophy measurement. (a) Spatial Distribution of the control population
around node i of the average shape. (b) Average distance µi and threshold µi + 3σi. (c) In
a shape j, the node i is labeled as 1 if its distance from the average node is higher than the
threshold. (d) The extent of atrophy is the percentage of nodes set to 1.
6.2.4 Pre-Statistical Shape Analysis
Does MMSE score correlate with severity of focal atrophy ?
We have assessed the significance of the correlation between the severity of focal atrophy and
MMSE score for each location (i.e. node) on the ventricular surface. Considering a particular
node in a given subject, one can evaluate its Euclidian distance in space to the corresponding
node in the average mesh, obtained from the control group. The underlying idea is that focal
atrophy in periventricular structures should lead to a more pronounced local ventricular en-
largement, and subsequently to larger distances between a given node and the corresponding
one in the average-control. We visually checked that all the non-control ventricles presented
larger structures than the average-control. For each node, the local enlargements across all
subjects were correlated with the corresponding MMSE scores: the statistical analysis and
the results are reported in section 6.3.1.
Does MMSE score correlate with the extent of atrophy ?
A similar approach was taken to evaluate the correlation between the MMSE score and the
extent of atrophy. Starting with the average mesh previously introduced, for each node i
we modeled the local distribution in space of the control population, evaluating the average
distance µi and the standard deviation σi (with i = 1, 2, .., NNodes) (see Fig. 6.2). Subse-
quently, considering a subject j, for each node i we evaluated its Euclidian distance dji to the
corresponding node in the average mesh. The location i in subject j was then labeled as:
lji =
{
1 if dji > µi + 3 ∗ σi,
0 otherwise.
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Figure 6.3: Local correlation between severity of atrophy and cognitive impairment, across all
subjects (controls and patients). Orthogonal (top) and prospective (bottom) views (p-values
higher than 0.05 are plotted in blue). The corresponding colored Figure can be found at page
viii, before the Introduction.
For each subject and for each region, we could therefore evaluate the percentage of locations
set to 1, corresponding to the local extent of atrophy. Such values were finally correlated,
across all subjects, with the MMSE scores: permutation tests were used to assess the signifi-
cance level (p-value) of the correlation. Results are reported in section 6.3.2.
6.3 Results
6.3.1 MMSE Correlation with Severity of Atrophy
For each given node, we performed a linear regression correlating local distances of all sub-
jects from the control average node, to the MMSE scores associated with the subjects. The
statistical significance of the correlation was assessed via permutation tests, correcting for
multiple comparisons. Thus, the results provided us, for each node, with a p-value indicat-
ing the significance of the correlation in that particular location. Mapping the p-values on
an average control, we could visually highlight areas with higher correlation (see Fig. 6.3).
Results were then clustered into the manually delineated regions, and for each region we
evaluated the percentage of surface in which the severity of atrophy significantly correlated
with the MMSE score: this made it possible to identify the regions (and, consequently, the
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Figure 6.4: Extent of correlation for the severity of atrophy. For each region, we plot the per-
centage of ventricular surface whose severity of atrophy (see Fig. 6.3) significantly correlates
with the MMSE score.
periventricular structures) with higher correlation. Figure 6.4 shows the percentage of area in
which the severity of atrophy correlates (p < 0.05) with the MMSE score, for each manually
delineated region (the whole, left, and right ventricular systems are also considered). Some
regions show a high correlation: left corona radiata, right caudate nuclei, left caudate nuclei,
left thalamus, and left medial temporal horn. Other regions, on the other hand, are almost
completely uncorrelated: right side of the corpus callosum, right side of the thalamus, left
inferior medial temporal horn. It is notable that the severity of atrophy in left periventricu-
lar structures (reflected in the left ventricular system) presents a higher correlation with the
MMSE score than those on the right.
6.3.2 MMSE Correlation with Extent of Atrophy
We performed a linear regression analysis to correlate the MMSE score and the extent of
atrophy for the whole, left, and right ventricular systems, as well as for each of the manually
delineated regions. All subjects were included in the analysis, and both the R2 statistic and
the corresponding p value were evaluated. Results are reported in Table 6.2. No significance
correlation was found in any of the analyzed areas. Only in the left inferior medial temporal
horn we could detect a trend, showing that higher MMSE scores reflect smaller extents of
atrophy: nevertheless, the correlation was not significant (p value = 0.06).
6.4 Discussion and Conclusions
In this work, we have investigated the correlation between atrophy in periventricular struc-
tures and cognitive function, in the spectrum from normal cognition to severe AD. The analy-
sis of structural changes in periventricular structures always presents some serious challenges.
First, one should choose between volumetric or shape-based analyses. In [28], the authors
analyzed a subset of the population used in this study, showing that MR volumetric mea-
surements of the brain correlate with cognitive decline in non-demented elderly. The volume
changes, being inherently global, are less subject to small segmentation errors; shape-based
methods, on the other hand, aiming at a localized analysis, are more sensitive to the accuracy
of the segmentation. Conversely, the volumetric distributions of periventricular structures in
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Table 6.2: Linear regression between extent of atrophy and MMSE score (all 112 subjects in-
cluded): for each area, we report the R2 value and the corresponding p value. No significance
correlation was found (p threshold set at 0.05).
R2 p-value
Whole Ventricle 0.01 0.67
Right Ventricle 10−6 1.00
Left Ventricle 0.03 0.40
Corona Radiata R 0.01 0.66L 0.01 0.75
Corpus Callosum R 0.03 0.39L 0.01 0.70
Caudate Nuclei R 0.03 0.39L 0.03 0.43
Thalamus R 0.001 0.88L 10−4 0.94
Sup. Med. Temp. Horn R 10
−4 0.92
L 0.05 0.31
Inf. Med. Temp. Horn R 0.003 0.78L 0.14 0.06
normal and non-normal populations might overlap and fail to provide discriminative results;
shape analysis, highlighting more localized differences, is less keen to this problem. Thus,
a shape-analysis of periventricular structures is to be preferred. Unfortunately, the intensity
contrast between white and gray matter decreases with age [23], making it a more difficult
and less accurate task to delineate periventricular structures in MR. On the other hand, the
contrast between CSF and the remaining parenchyma stays sharp in elderly, allowing auto-
matic tools to reliably segment ventricular CSF. In our study, we have analyzed shape changes
of the whole ventricular system as an indirect tool to investigate atrophy in the surrounding
periventricular structures: this differs from previous methods which focused more on sin-
gular gray/white matter structures or specific ventricular areas [15, 19, 20]. Moreover, we
introduced a clear separation between severity of atrophy and extent of atrophy, showing that
the former correlates with cognitive impairment, while the second does not: while doing this,
we explored a larger area in the spectrum of cognitive function, including both subjects with
MCI and AD, while previous methods focused more on AD [19, 20], on AD and a limited
number of converting MCI [22], or on converting and non-converting MCI [15].
The assessment of a subject’s cognitive function is not a trivial task. In this work, we
have chosen to use the MMSE score as an estimation of an individual’s cognitive level. This
choice was justified by the fact that, despite its limitations, the MMSE score is largely used
in the diagnostic work up of AD and MCI in clinical routine. Thus, a better understanding of
how the MMSE score relates to periventricular atrophy is important. Global measurements
of brain atrophy have already been proved to correlate with MMSE scores [29, 30]. The local
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analysis presented in this work aimed at further improving our knowledge on how damage in
specific periventricular structures contributes to the assessment of an individual’s cognitive
level.
The results lead to some further considerations. The severity of cognitive impairment
seems to correlate significantly with increased severity of atrophy in well-defined periven-
tricular structures. More specifically, areas like the left corona radiata, right and left caudate
nuclei, left side of the thalamus, left medial temporal horn, and the left side of the splenium
in the corpus callosum showed high correlation between severity of atrophy and cognitive
impairment. These findings are in agreement with those previously reported in the literature:
a correlation between dementia and infarcts in left corona radiata was highlighted in [31]; the
left temporal horn and its correlation with dementia is well-established [15, 19], and shows
how atrophy of the temporal lobe and hippocampus are inherently related with the disease;
involvement of the left side of the splenium in the corpus callosum was highlighted by [20],
by using global diffusion tensor images for healthy subjects and ADs. In [19], the authors
suggested that a lack of correlation between cognitive decline and hippocampal atrophy might
be due to the MMSE test itself, since it is mostly related with cortical functions. Our find-
ings on the thalamus might lead to some further considerations: the thalamus is responsible
to code and transmit information to the cortex, particularly for what concerns the sensory
system (auditory system, visual system, etc.): thus, impairments of cortical functions might
also occur as a consequence of thalamus deficits. Finally, looking at the whole, left, and right
ventricular systems, it is clear that the severity of atrophy in the left hemisphere presents a
higher correlation: this result is consistent with previous studies showing how changes in left
periventricular structures relate to dementia. When we tried to correlate the extent of atrophy
with cognitive function, we could not find any significant result. The only exception was
the left inferior medial temporal horn, which presented an almost significant correlation (p =
0.06).
The assumption that MMSE scores can confidently reflect cognitive impairment is open
to discussion. Neuropsychological tests usually provide a large set of indicators to estimate
the cognitive level of an individual. The MMSE test is a global composite measurement of
different cognitive functions, spatially located in different parts of the brain. Some criticisms
have been moved to the use of MMSE test, especially when assessing the cognitive level of
healthy subjects or patients with MCI. Nevertheless, the MMSE test keeps being intensively
used in the diagnosis of AD and MCI: thus, efforts to improve our understanding on its rela-
tion with brain structural changes are largely justified. To the best of our knowledge, this is
the first study which clearly distinguishes between different kinds of atrophy in periventric-
ular structures, and correlates them with cognitive impairment in MCI and AD, as estimated
by the MMSE score.
In conclusion, our results suggest that worse MMSE scores correlate with an increased
severity of atrophy in well-defined periventricular structures. Future research might focus
on other global tests, such as the Camcog, and more specific cognitive tests: a comparison
between tests could strength even further the link between cognitive impairment and atrophy
of well-defined periventricular structures.
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CHAPTER 7
Summary and Conclusions
Concern for man and his fate must always form the chief interest of all technical endeavors.
Never forget this in the midst of your diagrams and equations -
Try not to become a man of success, but rather a man of value.
Albert Einstein, 1879-1955.
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7.1 Summary and Conclusions
Since the first case of Alzheimer Disease was reported, many efforts have been spent to in-
vestigate the causes and mechanisms of this pathology. Therapies developed to slow down
the cognitive decline have been proved more effective if administered during the early stage
of the disease: consequently, biomarkers for early diagnosis are highly desirable. Growing
evidence of the correlation between the progression of AD and the loss of neurons in spe-
cific areas of the brain has been reported in the literature. Clinical MR images are a valuable
tool for the estimation of volume loss and shape changes in well-defined brain structures:
tissue degeneration due to AD has been shown both in gray matter structures, such as hip-
pocampus and amygdala, and in white matter structures, such as the corpus callosum. Thus,
investigating changes in these areas might increase our knowledge on the progression of AD.
Preliminary to any kind of analysis is the segmentation of the structures of interest. The de-
lineation of small white and gray matter structures remains a challenging task, particularly
in elderly subjects: the contrast between white and gray matter decreases with age, yielding
to error-prone and less reproducible (semi-) automatic segmentation algorithms. Manual de-
lineation, on the other hand, is more subjective and time consuming. The analysis of brain
ventricles could lead to more reproducible results since the contrast between CSF and the rest
of the parenchyma remains sharp with aging. Moreover, any change in volume and shape due
to atrophy in periventricular structures must be reflected on the shape and volume of the ven-
tricles. The focus of this research was to investigate changes in the ventricular shape within
different populations (i.e. healthy subjects, MCIs, and ADs), as well as across the whole
spectrum of cognitive impairment. The most relevant results are summarized in this section.
Chapter 1 introduces the general issues investigated in this manuscript: starting with a brief
overview on the history of medical imaging, the chapter continues presenting the anatomical
structures of interest for this research, and the Magnetic Resonance technique used to acquire
brain images. Subsequently, an overview of Alzheimer Disease is given, covering hypotheses
on its causes, societal and economical effects, cognitive and anatomical consequences, and
relevant research challenges. The chapter concludes with the issue of shape modeling and
analysis: the advantages of shape-based statistical models are presented, together with some
of the most relevant methods published in the literature.
Chapter 2 presents a newly developed method for shape modeling and analysis: Growing
and Adaptive MEshes (GAMEs). The method is based on Self-Organizing Networks which
Grow When Required and was introduced by Marsland et al. [1]. In a first phase, a mesh is
initialized with only two nodes randomly located in space: surface points from an average
instance are iteratively given to the network, which grows and adapts to model the instance’s
surface. After convergence, the mesh’s topology is frozen, and the mesh’s shape is adapted
to other similar instances: the set of comparable meshes form a Point Distribution Model.
Several aspects of the PDM were tested on challenging synthetic shapes: reproducibility, ro-
bustness to noise, and accuracy in detecting corresponding landmarks. Given the PDM, a
statistical model based on Principal Component Analysis was built and tested for compact-
ness, reconstruction error, generalization error, and specificity error. All the results proved to
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be satisfactory, when compared to similar approaches for medical image analysis. Moreover,
we tested the method’s performances in highlighting local shape differences between popu-
lations of similar instances: local comparisons with permutation tests highlighted the exact
locations where shape differences had been artificially introduced. Finally, we applied the
method to the modeling of two populations of brain ventricles, controls and AD: the statisti-
cal models were used to prove the good performances of our method in a challenging medical
application.
In Chapter 3, the method previously introduced was applied to the analysis of two popula-
tions of brain ventricles: patients with Alzheimer Disease, and age-matched healthy subjects.
The controls were used to create an average ventricle which was used to generate a first mesh.
Comparable meshes were then created to build up a PDM. A first analysis focused on intra-
population variability, showing the main modes of variation within each population by means
of tensor maps. Both in controls and AD, we could highlight asymmetrical variations be-
tween the left and right inferior temporal horns: AD were characterized by inferior-superior
widening in the right inferior medial temporal horn, and a more isotropic enlargement in the
left one; controls showed anterior-posterior elongation in the right inferior temporal horn, and
an inferior-superior thickening in the left one. Subsequently, permutation tests were applied
to detect local shape differences between populations: results showed that about 22% of the
total surface was significantly different (at a confidence level of 95%), of which 14% was on
the left side. By visual inspection, we could infer significant changes in areas close to tem-
poral horns, splenium of the corpus callosum, amygdala, thalamus, head of the left caudate
nuclei, and tail of caudate nuclei. Finally, for each of the significantly different regions we
evaluated displacement vectors showing the local deformations from an average control to an
average AD ventricle.
Chapter 4 investigates the existence of ventricular shape-based biomarkers for AD in clinical
MR images. Considering two populations of AD and age-matched healthy individuals, re-
peated permutation tests were run on randomly sub-sampled AD groups and controls to high-
light locations on the ventricle’s surface which consistently discriminated the two groups:
by applying different thresholds on the p values, more specific regions could be identified,
such as the tips of the inferior temporal horns, the right superior temporal horn, the head of
the right caudate nuclei, and the genu of the corpus callosum. These areas were then used
to train a support vector machine to discriminate between healthy subjects and ADs. The
most successful classification was achieved when only the tips of the inferior temporal horns
were used: leave 1 out experiments showed an overall accuracy of 84%, while the sensitivity
on a previously unseen AD dataset reached 76%. Our results were compared with previous
methods [2–6], proving the good performances of our approach.
Chapter 5 extends the results presented in Chapter 3 to other populations, covering a larger
part of the cognitive spectrum. Healthy elderly are compared to Memory Complainers, pa-
tients with Mild Cognitive Impairment, and subjects affected by AD. Permutation tests high-
lighted different patterns of shape differences for the different groups, supporting the classifi-
cation based on neuropsychological tests. Shape changes (both in terms of extent of affected
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surface and severity of changes) reflected atrophy in the surrounding structures: different re-
gions were delineated along the ventricular surface, and results were clustered according to
the adjacent periventricular structures. When comparing controls versus a particular group
(e.g., AD), we could indicate relevant asymmetries in the way the pathology affects periven-
tricular structures (e.g. major atrophy on the right side for MC and MCI, and on the left
side for AD); when focusing on a given region (e.g., close to the caudate nuclei), we could
investigate trends across the cognitive spectrum.
In Chapter 6, we correlate local ventricular enlargements in brain ventricles with the degree
of cognitive impairment. Subjects were included to cover the entire spectrum of cognitive
function, ranging from healthy controls to severe cases of AD. The degree of cognitive im-
pairment was estimated, for each subject, with the Mini Mental State Examination (MMSE).
Atrophy in periventricular structures was inferred by shape analysis of the ventricular surface.
The amount of local enlargement in the ventricle, with respect to an average normal control,
was used to estimate the severity of focal atrophy in periventricular structures; the amount
of surface significantly different between a given subject and the average control was used to
estimate the extent of atrophy in periventricular structures. The surface of the ventricles was
clustered in different regions, each corresponding to adjacent anatomical structures. Linear
regression analysis was used to correlate both the severity of atrophy and the extent of atrophy
with the MMSE score. Results showed that the severity of atrophy correlates with cognitive
impairment in well-defined periventricular structures: left side of the thalamus, left temporal
horn, left corona radiata, and right caudate nuclei. The extent of atrophy, on the other hand,
does not correlate in any of the analyzed regions. Results suggest that worse cognitive con-
ditions are a consequence of an increased severity of atrophy in well-defined periventricular
structures.
A better understanding on how Alzheimer Disease affects the brain is an important step to-
wards the development of new therapies and the discovery of potential biomarkers. Quanti-
tative measurements of localized atrophy in MR images are extremely important to this goal.
In this thesis, we have shown that quantitative analysis of ventricular shape changes is a pow-
erful tool to estimate atrophy in periventricular structures. A new method for shape modeling
and analysis of brain ventricles was introduced and thoroughly validated, both on challenging
synthetic shapes and medical images. Combining our method with non-parametric statistical
tests and pattern recognition tools, we achieved new insights on how AD and MCI affect
periventricular structures. Further analyses based on linear regression highlighted the corre-
lation between cognitive impairment (assessed by the MMSE score) and focal atrophy. In
conclusion, the goals of this research stated in Section 1.3 have been achieved.
7.2 Future Work
The shape modeling algorithm introduced in this thesis presents some advantages when com-
pared to other methods: it can model objects with non-spherical topology, it is highly auto-
matic, and its surface parametrization is straightforwardly linked to the shape properties of
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the objects. Nevertheless, some characteristics could be improved in the future. First of all,
the Euclidian and Mahalanobis distance functions used in the growing and adaptive phase are
based on spatial information; different distance functions considering surface connectivity
should be implemented to improve the results in particular applications: for instance, dis-
tance measurements between locations on the brain cortex should take into account whether
the nodes are on different gyri. Moreover, additional information could be introduced: nodes
in a mesh are currently described by their spatial coordinates; the method could easily be
extended to include a fourth dimension, such as intensity or a given label, to facilitate the
modeling of non-binary structures or to allow for the simultaneously modeling of different
structures. Finally, because of its generality, the method could be used for different applica-
tions.
The results achieved in the analysis of brain ventricles suggest several new research di-
rections. The discrimination between MCI and AD could be further investigated in a lon-
gitudinal study: future analyses could incorporate knowledge on the MCI state (converters
or non-converters). A longitudinal comparison between healthy individuals and subjects de-
veloping AD would also provide more insights on the developing of the disease. Moreover,
the correlation between cognitive decline and atrophy in periventricular structures could be
strengthened by using different neuropsychological tests, such as the Camcog.
The combination of different image modalities and more invasive techniques could also
improve the diagnosis of dementia in general, and AD in particular. Recent studies have
shown that CSF biomarkers (i.e. concentration of beta amyloid and total tau) could improve
the detection of AD [7], especially if combined with MR-based quantitative analysis [8].
Other studies have investigated the use of nuclear imaging (PET) to highlight the increase of
amyloid plaques in AD and MCI [9–11]. Finally, studies on functional MRI have shown that
differences in resting-state activation networks could be used to discriminate between healthy
subjects, MCIs and ADs [12–14].
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CHAPTER 8
Samenvatting en Conclusies
Niels Bohr and Albert Einstein at Ehrenfest’s house in Leiden (December 1925)
Prediction is always difficult, especially if it’s about the future -
An expert is a man who has made all the mistakes which can be made in a very narrow field.
Niels Bohr, 1885-1962.
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8.1 Samenvatting en Conclusies
Sinds het eerste geval van Alzheimer Disease werd gerapporteerd, zijn er vele pogingen
gedaan om de oorzaken en de uitwerkingen van deze ziekte te onderzoeken. Therapiee¨n die
ontwikkeld zijn om de cognitieve daling te vertragen, hebben bewezen efficie¨nter te zijn als
deze al een vroeg stadium van de ziekte toegepast worden: daarom zijn biomarkers voor een
vroege diagnose zeer wenselijk. In de literatuur is wezenlijk bewijs van de correlatie tussen
de vooruitgang van AD en het verlies van neuronen in specifieke gebieden van de hersenen
beschreven. Klinische MRI beelden zijn een waardevol hulpmiddel om volumeverlies en vor-
mveranderingen in specifieke hersenenstructuren te schatten: weefseldegeneratie als gevolg
van AD is zowel in de grijze stof (zoals de hippocampus en de amygdala) als in de witte stof
(zoals in het corpus callosum) aangetoond. Dus zou het analyseren van veranderingen in deze
gebieden onze kennis over de progressie van AD kunnen vergoten. Voordat het mogelijk is
om een analyse te doen is, moeten de structuren die van belang zijn worden gesegmenteerd.
Een onderscheid maken tussen kleine structuren in de witte en grijze stof is een moeilijke
taak, vooral in de hersenen van ouderen: het contrast tussen witte en grijze stof vermindert
met leeftijd en daarom kunnen de (half-)automatische segmentatie algoritmen falen en zijn
minder reproduceerbaar. Handmatige segmentatie, anderzijds, is subjectiever en tijdroven-
der. De analyse van hersenventrikels kan tot reproduceerbaardere resultaten leiden, omdat
het onderscheid tussen het CSF (hersenvocht) en de rest van het parenchym (hersenweefsel)
met het verouderen duidelijk zichtbaar blijft. Bovendien spiegelen verandering in volume
en vorm van periventriculaire structuren als gevolg van AD zich af op het volume en vorm
van de hersenventrikels. In dit onderzoek wilden we de veranderingen van hersenventrikels
analyseren, zowel binnen verschillende populaties (d.w.z. gezonde individuen, MCI, en AD)
als in de breedte van de cognitieve spectrum. De meest relevante resultaten worden in deze
sectie samengevat.
Hoofdstuk 1 introduceert de algemene onderzochte kwesties in dit manuscript: het begint
met een kort overzicht van de geschiedenis van medische beeldvorming, waarna het hoofd-
stuk anatomische structuren introduceert die belangrijk zijn voor dit onderzoek, samen met
de Magnetische Resonantie techniek die wordt gebruikt om hersenenbeelden te verwerven.
Vervolgens wordt een overzicht van de Ziekte van Alzheimer (AD) gegeven, waarin hypothe-
sen over de oorzaken, de sociale en economische gevolgen en de cognitieve en anatomische
uitwerkingen behandeld worden, alsmede de openstaande onderzoeksvragen voor relevant
onderzoek. Het hoofdstuk besluit met het modelleren en analyseren van vormen: de voorde-
len van op vorm gebaseerde statistische modellen worden gegeven samen met een aantal van
de meest relevante methodes die in de literatuur zijn gepubliceerd.
Hoofdstuk 2 introduceert een nieuwe methode van vorm modellering en analyse: Growing
and Adaptive MEshes (GAMEs). De methode is gebaseerd op de Self-Organizing Networks
which Grow When Required, geı¨ntroduceerd door Marsland et al. [1]. In de eerste fase wordt
een netwerk geı¨nitialiseerd met slechts twee knooppunten die willekeurig in ruimte worden
geplaatst: punten aan het oppervlak van een gemiddelde instantiatie worden achtereenvol-
gens aan het netwerk gegeven, zodat het groeit en zich aanpast om zo de oppervlakte van de
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instantiatie te modelleren. Na convergentie wordt de topologie van het netwerk bevroren en
wordt de vorm van het netwerk aangepast aan andere, gelijksoortige instantiaties: deze set van
vergelijkbare netwerken vormt een Point Distribution Model (PDM). Verscheidene aspecten
van het PDM werden getest met complexe synthetische vormen: reproduceerbaarheid, robu-
ustheid voor ruis en nauwkeurigheid in het ontdekken van overeenkomstige orie¨ntatiepunten.
Aan de hand van het PDM werd een statistisch model, gebaseerd op de Principal Component
Analysis, geconstrueerd en getest voor compactheid, reconstructiefout, generalisatiefout, en
specificiteitfout. Alle resultaten bleken voldoende vergeleken met gelijksoortige methodes
voor medische beeldanalyse. Bovendien hebben wij de prestaties van de methode getest
op het accentueren van lokale vormverschillen tussen populaties van gelijksoortige instan-
tiaties: lokale vergelijkingen met permutatietests benadrukten de exacte plaatsen waar de
vormverschillen kunstmatig waren geı¨ntroduceerd. Ten slotte pasten wij de methode toe op
het modelleren van twee groepen hersenventrikels; gezonde individuen en AD. De statistis-
che modellen werden gebruikt om de goede prestaties van onze methode in een moeilijke
medische toepassing te bewijzen.
In Hoofdstuk 3, werd de eerder geı¨ntroduceerde methode toegepast op de analyse van twee
populaties van hersenventrikels: patie¨nten met de Ziekte van Alzheimer en gezonde indi-
viduen van vergelijkbare leeftijd. Vanuit de controle groep werd een gemiddeld ventrikel
geconstrueerd, dat werd gebruikt om een eerste netwerk te produceren. Daarna werden soort-
gelijke netwerken gecree¨erd om een PDM te construeren. Een eerste analyse concentreerde
zich op intra-groep variatie die de belangrijkste vormen van variatie binnen elke groep aan-
toont door middel van tensormaps. Zowel in de controle groep als in de AD populatie kon-
den wij asymmetrische variaties tussen de linker en rechter inferieure temporale hoornen
laten zien: de AD werd gekenmerkt door inferieure-superieure verwijdingen in de rechter
inferieure mediale temporale hoorn en een meer isotrope vergroting in linker; de controles
toonden een anterieure-posterieure verlenging in de rechter inferieure temporale hoorn en een
inferieure-superieure verdikking in linker. Daarna werden de permutatietests toegepast om
lokale vormverschillen tussen populaties te ontdekken: de resultaten lieten zien dat ongeveer
22% van de totale oppervlakte significant verschillend was met een confidence interval van
95%, waarvan 14% aan de linkerkant zat. Door visuele inspectie konden wij significante
veranderingen aanwijzen in gebieden dicht bij temporale hoornen, splenium van het corpus
callosum, amygdala, thalamus, kop van de linker nucleus caudatus en de staart van de nu-
cleus caudatus. Ten slotte werden voor elk van de significant verschillende gebieden de ver-
plaatsingsvectoren gee¨valueerd die de lokale vervormingen aangaven tussen een gemiddelde
controle ventrikel en een gemiddeld ventrikel van de AD.
Hoofdstuk 4 onderzoekt het bestaan van ventriculaire vormgebaseerde biomarkers voor AD
in klinische MR beelden. Twee populaties werden samengesteld (AD en gezonde indi-
viduen van vergelijkbare leeftijd), waarbij herhaalde permutatietests werden uitgevoerd op
de willekeurige sub-groepen van de AD en de gezonde individuen om vaste plaatsen op de
oppervlakte van het ventrikel te vinden die de twee groepen onderscheidde: door verschil-
lende thresholds op de p-waarden konden we specifiekere gebieden identificeren, zoals de
uiteinden van de inferieure temporale hoornen, de rechter superieure temporale hoorn, de
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kop van de rechter nucleus caudatus, en de genu van het corpus callosum. Deze gebieden
werden gebruikt om een support vector machine te trainen om onderscheid te maken tussen
gezonde individuen en AD. De meest succesvolle classificatie werd bereikt toen slechts de
uiteinden van de inferieure temporale hoornen werden gebruikt: ”leave 1 out” experimenten
lieten een algemene nauwkeurigheid van 84% zien, terwijl de sensitiviteit op een onbekende
dataset van de AD 76% haalde. Onze resultaten werden vergeleken met eerdere methodes
[2–6] waardoor de goede prestaties van onze benadering worden bewezen.
Hoofdstuk 5 breidt de resultaten die in Hoofdstuk 3 gepresenteerd zijn, uit naar andere pop-
ulaties die een groter deel beslaan van het cognitieve spectrum. Gezonde ouderen worden
vergeleken met ouderen met geheugenklachten (Memory Complainers), milde cognitieve be-
schadigingen (Mild Cognitive Impairment), en de ziekte van alzheimer (AD). Permutatie
tests lieten verschillende voorbeelden van vormverschillen voor de verschillende groepen
zien die overeen kwamen met de classificatie op basis van neuropsychologische tests. Vor-
mveranderingen (zowel in omvang van aangetast ventrikeloppervlakte als de mate van de
veranderingen) wezen op atrofie in de aangrenzende structuren: de verschillende gebieden
werden ingetekend langs de ventriculaire oppervlakte en de resultaten werden geclusterd
volgens de aangrenzende periventriculaire structuren. Door controles te vergelijke met een
bepaalde groep (b.v., AD), konden we relevante asymmetriee¨n als gevolg van de invloed van
de pathologie op de periventriculaire structuren aanwijzen (b.v. belangrijke atrofie aan de
rechterkant voor MC en MCI, en aan de linkerkant voor AD); door te concentreren op een
bepaald gebied (b.v. dicht bij de nucleus caudatus), konden we trends over het cognitieve
spectrum onderzoeken.
In Hoofdstuk 6, correleren we lokale ventriculaire vergrotingen van de hersenenventrikels
aan de mate van de cognitieve beschadiging. Patie¨nten werden toegevoegd om het volledige
spectrum van cognitieve functie te dekken, dat zich uitstrekt van gezonde ouderen tot aan
ernstige gevallen van AD. De mate van de cognitieve beschadiging werd voor elk individu
geschat met het Mini Mental State Examination (MMSE). Atrofie in periventriculaire struc-
turen werd aangeduid door vorm analyse van de ventriculaire oppervlakte. De mate van
lokale verwijding van het ventrikel, vergeleken met een gemiddelde normale ventrikel, werd
gebruikt om de graad van atrofie in periventriculaire structuren te schatten; het aantal sig-
nificant verschillende oppervlaktes tussen een bepaalde patie¨nt en de gemiddelde controle
groep werd gebruikt om de omvang van atrofie in periventriculaire structuren te schatten. De
ventrikeloppervlakte werd verdeeld in verschillende gebieden corresponderend aan de aan-
grenzende anatomische structuren. De lineaire regressie analyse werd gebruikt om de mate
en de omvang van atrofie met de MMSE score te correleren. De resultaten bewezen dat de
mate van atrofie correleert met de cognitieve beschadigingen in specifieke periventriculaire
structuren: de linkerkant van de thalamus, de linker temporale hoorn, de linker corona radi-
ata, en de rechter nucleus caudatus. Echter, de atrofie omvang correleert met geen enkele van
de geanalyseerde gebieden. De resultaten suggereren dat de slechtere cognitieve condities
een gevolg zijn van een hogere mate van atrofie in specifieke periventriculaire structuren.
Een beter begrip over hoe de Ziekte van Alzheimer de hersenen beı¨nvloedt is een belan-
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grijke stap richting de ontwikkeling van nieuwe therapiee¨n en de ontdekking van potentie¨le
biomarkers. De kwantitatieve metingen van gelokaliseerde atrofie in MR beelden zijn enorm
belangrijk voor dit doel. In deze thesis, hebben wij aangetoond dat de kwantitatieve anal-
yse van ventriculaire vormveranderingen een krachtig hulpmiddel is om atrofie in periven-
triculaire structuren te schatten. Een nieuwe methode voor modellering van vorm en anal-
yse van hersenenventrikels werd geı¨ntroduceerd en grondig gevalideerd, zowel op complexe
synthetische vormen als medische beelden. Door onze methode te combineren met niet-
parametrische statistische tests en patroonerkennings methoden, hebben wij nieuw inzicht
bereikt in hoe de AD en MCI periventriculaire structuren beı¨nvloeden. De analyses, gebaseerd
op lineaire regressie, benadrukten de correlatie tussen cognitieve stoornissen (die door de
MMSE score wordt beoordeeld) en gelokaliseerde atrofie. Samenvattend, de doelstellingen
van dit onderzoek, die in Sectie 1.3 worden genoemd, zijn gehaald.
8.2 Aanbevelingen
Het Shape Modeling algoritme dat in deze thesis wordt geı¨ntroduceerde heeft een aantal vo-
ordelen vergeleken met andere methodes: het kan voorwerpen met niet-sferische topologie
modelleren, het is hoog automatisch, en zijn oppervlakte- parameterisatie is rechtstreeks ver-
bonden met de vormeigenschappen van de objecten. Niettemin zouden sommige eigenschap-
pen in de toekomst kunnen worden verbeterd. Allereerst zijn de Euclidische en Mahalanobis
afstandsfuncties die in de groei- en de aanpassingsfasen worden gebruikt, gebaseerd op
spatie¨le informatie; andere afstandsfuncties die oppervlakte connectiviteit berekenen, moeten
worden geı¨mplementeerd om de resultaten van specifieke toepassingen te verbeteren: bi-
jvoorbeeld op het hersenschors zouden afstandsfuncties rekening moeten houden met knopen
die op verschillende gyri liggen. Verder zou extra informatie kunnen worden toegevoegd: de
knopen in een netwerk worden nu beschreven door hun spatie¨le coo¨rdinaten; de methode
kan gemakkelijk worden uitgebreid met een vierde dimensie, zoals intensiteit of een bepaald
label, om ook niet binaire structuren of verschillende structuren tegelijkertijd te modelleren.
Ten slotte zou de methode voor verschillende toepassingen kunnen worden gebruikt, omdat
hij zeer generiek is.
De bereikte resultaten in de analyse van hersenenventrikels impliceren verscheidene nieuwe
onderzoeksrichtingen. Het onderscheid tussen MCI en de AD zou in een longitudinale studie
verder onderzocht kunnen worden: toekomstige analyses zouden kennis kunnen opnemen
omtrent de MCI status (converters of non-converters). Een longitudinale vergelijking tussen
gezonde individuen en individuen die AD ontwikkelen zou ook meer inzicht geven in het
zich ontwikkelen van de ziekte. Bovendien zou de correlatie tussen cognitieve daling en
atrofie in periventriculaire structuren kunnen worden versterkt door deze te vergelijken met
verschillende neuropsychologische tests, zoals de Camcog.
Ook kan de combinatie van verschillende beeldmodaliteiten en meer invasieve technieken
de diagnose van dementie in het algemeen en AD in het bijzonder verbeteren. Recente studies
hebben aangetoond dat CSF biomarkers, d.w.z. concentratie van beta-amyloid en totale tau,
de opsporing van AD konden verbeteren [7], vooral wanneer ze gecombineerd worden met op
MR-gebaseerde kwantitatieve analyse [8]. Andere studies hebben het gebruik van nucleare
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beeldvormende technieken (PET) onderzocht om de verhoging van amyloid plaques bij AD
en MCI te meten [9–11]. Ten slotte hebben de studies met functionele MRI aangetoond dat in
de resting state de verschillen in netwerken gebruikt zouden kunnen worden om onderscheid
te maken tussen gezonde patie¨nten, MCIs en ADs [12–14].
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